The present disclosure relates to devices and methods for the fixation of tissues and/or implants in a body of a patient. Embodiments may include devices and methods for securing, approximating, and repairing any soft and/or hard body tissue of humans or other animals.
Traditional devices and methods may be configured to achieve fixation along a straight line, for example utilizing straight screws, pins, plates, and rods. In many procedures, these devices primarily purchase harder cortical bone and sometimes cancellous bone. Fractures, especially at or near a joint, may include fragments, for example smaller bone fragments and/or soft tissues attached to the bone fragments. The soft tissues connected to the bone fragments may be necessary for blood flow to these bone fragments but are traditionally not addressed. Detaching the soft tissues from the bone fragments may, for example, weaken the muscular attachments and/or devascularize the bone fragments. Traditional techniques lead to further deterioration of tissues surrounding the fracture.
Also, traditional devices may include implants that are designed to stabilize a larger portion of a fracture but may have difficulty securing soft tissue fragments (i.e. connective tissues) and/or hard tissue fragments (i.e. bone) associated with an injury. These tissues may traditionally be left to heal without support, wrapped with a cable, or drilled through then supported with a wire or pin. Traditional methods may result in periosteal stripping and neurovascular injury resulting from placement of the wire. Also, traditional wires and pins are typically smooth and straight thereby providing limited compression across and access to the fracture. Traditional techniques may be unable to capture soft and hard tissue fragments.
In addition, traditional devices and methods do not secure articular surface fragments. The articular surface must move relative to the adjacent tissues, so a traditional fixation device grabbing an articular surface fragment risks damage to the articular cartilage and the bone on the opposing side of the joint. For example, if the humeral articular surface is damaged, traditional methods do not provide a consistent way to repair the humeral articular cartilage back to its normal size and position. More rigid fixation may damage the glenoid of the articular surface on the opposing side of the joint as the shoulder moves through its range of motion. Traditional techniques are unsuitable for articular surfaces.
There exists a need for a system to repair and secure soft tissue fragments (i.e. muscle, tendon, ligament, and/or articular cartilage) along with hard tissue fragments (i.e. bone). Furthermore, there is a need for a system to repair traditionally unsecured soft tissue fragments thereby stabilizing soft and hard tissue fragments together as a unit. The fixation systems disclosed herein, for example deformable, suture material, and/or mesh fasteners, may secure hard and soft tissue fragments to another device (i.e. plate, screw, and rod), for example, to increase stability. The systems herein may allow capture of a hard tissue fragment (i.e. bone) of a fracture and closure the fracture with a desired compression. This may promote improved tissue healing and/or alleviate issues associated with traditional fixation systems. The systems disclosed herein may be a unitary or standalone solution or be coupled with plates, rods, screws, cables, pins, wires, and/or any traditional system.
As is described in further detail below, embodiments may include a system for securing first and second body tissue portions of a fracture. Fixation devices may include a base component, an insert component, and a flexible member. The base and/or insert components may include a passage. The insert component may be positionable within at least a portion of the passage of the base component. The elongate member may be configured to be positioned through the first and second body tissue portions. The elongate member may be tensioned and pinched between the base component and insert component or within the passage of the insert component, for example, to secure the first and second body tissue portions.
Further embodiments may include a fixation device, an elongate member, and a bone clamp. The elongate member may be configured to be positioned through first and second body tissue portions. The bone clamp may be configured to urge the first and second body tissue portions together. The elongate member may be tensioned and secured with the fixation device to secure the first and second body tissue portions.
In another embodiment, a system may include a base component, insert component, fastener, and elongate member. The base component may include a passage. The insert component may be positionable within at least a portion of the passage of the base component. The fastener may be configured to be positioned through the first and second body tissue portions and on a distal tissue surface. The elongate member may be configured to connect the fastener on the distal body tissue surface and positioned between the base component and insert component on a proximal tissue surface. The elongate member may be tensioned and pinched between the base component and insert component to secure fixation device relative to the elongate member thereby securing the first and second tissue portions.
Embodiments may also include methods of positioning first and second body tissue portions. Methods may include passing a fastener connected to an elongate member through first and second body tissue portions, securing the fastener relative to a distal body tissue surface, positioning a base component of a fixation device along the elongate member, tensioning the elongate member, and/or positioning an insert component of a fixation device into a portion of the base component and against the elongate member. The elongate member may be pinched between the base component and insert component thereby securing the first and second body tissue portions relative to each other.
As an additional embodiment, methods may include positioning a fixation system for securing a fracture of a joint of a body. The method may comprise passing a fastener connected to an elongate member through proximal and distal fragments of the fracture, positioning the fastener against the distal fragment, securing a plate with respect to the proximal fragment, tensioning the elongate member to urge the first and second fragments together, and/or locking a fixation device against the elongate member and the plate.
Further embodiments may include a method of using a fixation system to repair a defect in a passage. The method may comprise positioning an implant disposed over an introducer adjacent the defect in the passage, expanding the introducer radially to urge the implant against the passage, contracting the introducer radially while the implant remains expanded against the passage; and retracting the introducer axially while the implant remains in the passage.
Additional embodiments of the present disclosure are provided throughout this disclosure including the accompanying drawings.
A more complete understanding of the present disclosure, and the attendant advantages and features thereof, will be more readily understood by reference to the following detailed description when considered in conjunction with the accompanying drawings wherein:
The present disclosure relates to devices and methods for fixation of tissues in a body of a human or other animal. Embodiments may include a fixation device comprised of a single or one or more components. The fixation device may be attached relative to an elongate member, for example, to secure soft and/or hard body tissues. The fixation device may be used alone, with one or more other fixation devices, or may be used with fasteners, screws, plates, rods, cables, pins, and/or wires. One or more fixation device may be utilized to secure a single or one or more elongate members.
Embodiments may relate to the repair, reconstruction, augmentation, and stabilization of tissue and/or implants. Embodiments may be utilized during a medical procedure and/or “on the way out” after the procedure has been performed. Hard and/or soft tissue at and around the procedure site and the tissue between the procedure site and the skin incision may be compressed and/or repaired. This may entirely or partially restore tissue function and/or stabilize the treatment area for enhanced healing. The embodiments herein may be used with any medical or surgical procedure, for example a ligament repair, tendon repair, muscle repair, bone repair, cartilage repair, and repair of any other tissue type. Ligaments may be fastened to ligaments, ligaments to bones, bones to bones, ligaments to muscles, muscles to muscles, tissue grafts to bone, tissue grafts to ligaments, grafts to grafts, and any other combination of tissues and/or implants. The embodiments herein may be utilized with minimally invasive techniques.
Embodiments herein may be configured to repair soft tissue (i.e. muscle, tendon, ligament, and/or articular cartilage) fragments along with hard tissue (i.e. bone) fragments together as a unit. Traditional screws and pins may be insufficient to stabilize the fragments. However, fixation devices, for example including deforming, all suture material, and/or mesh fasteners, may grab and stabilize bone along with muscles, tendons, ligaments, and/or articular cartilage. Also, fixation devices may reattach these tissues to larger structures (i.e. plates, screws, rods, and/or other implants) to create a more stable construct.
Further embodiments may be configured for soft tissue fragments, for example, to restore an articular surface. For example, a deformable fastener connected to an elongate member may be positioned through an articular cartilage fragment to pull the articular cartilage fragment to the articular surface. This may facilitate range of motion of the joint while minimizing damage to the bone on the opposite side of the joint, for example a glenoid or any other joint surface.
The technologies disclosed herein also allow for fixation of bone-to-bone, tissue-to-bone, and/or tissue-to-tissue. Bone fractures may damage the soft tissues (i.e. tendons and/or ligaments) near the fracture. The embodiments herein may allow for a composite system that may provide stability while repairing the tissue around the fracture. For example, embodiments may be used to repair an anterior cruciate ligament (ACL) or stabilize an ACL graft, allograft and/or autograft. Embodiments may also be used for rotator cuff tendon repair in which the tendon could be repaired around the tendon or around the bone. Also, bone-to-bone fixation may be achieved by grasping the tendon bone construct.
Embodiments may provide broader capabilities in fixing different types of fracture fragments. In situations with osteoporotic bone or other deteriorated tissues, the tendon-bone interface or ligament-bone interface may be stronger than an osteoporotic or deteriorated cortical portion. Fixation may be achieved by securing to the tendon or ligament portion, which may be more stable than grabbing the osteoporotic bone fragment alone. As another example, embodiments may be used in pediatric fractures where there may be a growth plate-epiphysis. An elongate member may be positioned through the epiphysis without the unnecessary bone growth restriction that may be a consequence of rigid fixation such as a screw, plate, or rod. The embodiments herein may be configured for soft tissue fixation by providing an angle, bend, or curve to avoid or access through a passage through the epiphysis. These techniques may facilitate treatment while preserving tissue and/or reducing growth abnormalities.
In an embodiment, devices and methods for stabilizing and/or repairing a body joint may be provided. A fixation device (i.e. a fastener) may be positioned in contact with a first body tissue, for example, on one side of the joint (i.e. at a distal area). Another fixation device may be positioned in contact with second body tissue, for example, on the other side of the joint (i.e. at a proximal area). An elongate member may be positioned and/or connected between the fixation devices and/or tensioned. The tensioned elongate member may be secured to the fixation devices, for example, to restrict or restore normal movement of the joint. The fixation devices may be positioned in contact with any outer or inner surface of the body.
The elongate member may be positioned adjacent to and/or through the tissue, for example, of the joint. The elongate member may include a suture, wire, cable, or any combination thereof. Elongate members may be flexible or bendable. The elongate member may include one or more flexible filaments. All or any portion of elongate member may be degradable, biodegradable, bioabsorbable, or non-biodegradable. The elongate member may be configured to change shape or dimensions with energy, for example thermal or vibratory energy (i.e. ultrasonic energy). Elongate member may tighten, loosen, and/or contract with heat. Heat may include body heat a portion of the body or applied thermal or vibratory energy. The elongate member may include polyethylene, polyester, cat gut, silk, nylon, polypropylene, linen, cotton, PLA, PGA, caprolactam, and copolymers of glycolic and lactic acid. The elongate member may be threadlike, monofilament, multifilament, braided, woven, or inter-laced. The elongate member may include a coating of therapeutic substances or drugs. The elongate members may include anti-biotics, hydroxyapatite, anti-inflammatory agents, steroids, antibiotics, analgesic agents, chemotherapeutic agents, bone morphogenetic protein, demineralized bone matrix, collagen, growth factors, autogenetic bone marrow, progenitor cells, calcium sulfate, immunosuppressants, fibrin, osteoinductive materials, apatite compositions, fetal cells, stem cells, enzymes, proteins, hormones, and germicides.
Body tissue may include any soft tissue, hard tissue, or any combination thereof. Body tissues may include bones, muscles, ligaments, tendons, nerves, fascia, skin, fibrous tissues, fat, synovial membranes, organs, collagen, cartilage, fascia, blood vessels, and tissue grafts. These may be tissues of any portion of the body, for example a knee, ankle, elbow, wrist, feet, hand, hip, shoulder, jaw, and spine. Bones of the knee may include the femur, tibia, and patella. Ligaments of the knee may include the medial collateral ligament, lateral collateral ligament, posterior oblique ligament, arcuate ligament, oblique popliteal ligament, anterior cruciate ligament, and posterior cruciate ligament. Bones of the spine may include transverse process, pedicle, facet, spinous process, posterior arch, odontoid process, posterior tubercle, lateral articular process, uncinate process, anterior tubercle, carotid tubercle, lamina, and vertebral body. Ligaments of the spine may include the anterior longitudinal ligament, posterior longitudinal ligament, interspinous ligaments, supraspinous ligament, ligamentum flavum, intertransverse ligament, facet capsulary ligament, ligamentum nuchae, and ligaments of the sacrum and coccyx spine. Tissue grafts may include a xenograft, allograft, autograft, and/or synthetic graft material. Embodiments may also be made from a porous matrix or mesh of biocompatible and bioresorbable fibers acting as a scaffold to regenerate tissue. Embodiments may be configured to repair or stabilize articular surfaces, metaphyseal areas, periarticular fractures, implants (i.e. cochlear implants), oral or facial injuries (i.e. oral maxillary facial injuries), and arthroplasty components of any joint including the spine.
Further embodiments may be degradable, biodegradable, bioerodible, bioabsorbable, mechanically expandable, hydrophilic, bendable, deformable, malleable, riveting, threaded, toggling, barbed, bubbled, laminated, coated, blocking, pneumatic, one-piece, Morse taper, single piece, multi-component, solid, hollow, polygon-shaped, pointed, locking and unlocking, self-introducing, knotless, and combinations thereof. Also, embodiments may include a metallic material, polymeric material, ceramic material, composite material, body tissue, synthetic tissue, hydrophilic material, expandable material, compressible material, heat bondable material, biocompatible adhesive, porous material, matrix or mesh material, and combinations thereof. All or any portion of the embodiments herein may include an expandable material and/or an expandable coating. The embodiments may be configured to be compressed then expanded. Alternatively, embodiments may be hydrophilic, expandable with liquid, PEEK, PTFE, desiccated body tissue, and/or any other material disclosed herein. Embodiments may include any combination of materials disclosed herein. For example, embodiments may include combinations of hydrophilic material, synthetic body tissue, collagen, synthetic collagen, heat bonded material, biocompatible adhesive, and cells (i.e. stem cells). Embodiments may include or be used in conjunction with any devices and methods disclosed in U.S. Pat. No. 5,718,717, titled “Suture Anchor”, which is hereby incorporated by reference in its entirety.
Embodiments may be any of biocompatible, degradable, biodegradable, bioerodible, bioabsorbable, mechanically expandable, hydrophilic, bendable, deformable, malleable, riveting, threaded, toggling, barbed, bubbled, laminated, coated, blocking, pneumatic, one-piece, multi-component, solid, hollow, polygon-shaped, pointed, self-introducing, mesh, segmented, tubular, braided, suture material, elastic (i.e. rubber, silicone, or any other elastic material), and combinations thereof. Furthermore, embodiments may include any of a metallic material, polymeric material, ceramic material, composite material, body tissue, synthetic tissue, hydrophilic material, expandable material, compressible material, bondable material, and combinations thereof. Embodiments may also include polymethyl methacrylate (PMMA or “bone cement”), glue, adhesive, grouting agents, acrylic materials, and combinations thereof.
Additional embodiments herein may include any biocompatible materials or any other materials suitable for medical use. All or any portion of the embodiments herein may be any metallic, non-metallic, composite, ceramic, polymeric, copolymeric, biologic, or synthetic material or any combination thereof. Embodiments may include portions and/or combinations of metals and polymers. Embodiments may include shape memory alloys (SMA) and/or shape memory polymers (SMP). Examples of amorphous polymers are polycarbonate (LEXAN), polystyrene, polysulfone (ULDALL), and acrylics polycarbonate (ABS and styrenes). Examples of semi-crystalline polymers include acetyl (DELRIN), nylon, polyester, polyethylene, polyether ether ketone, polypropylene, polyvinylchloride (PVC), and Caprolactam. Biodegradable semi-crystalline polymers may include polylactic acid and polyglycolic acid. Copolymers of PGA and PLA may also be used. Poly-1-lactide (PLLA) or other forms of PLA may also be used. Other polymers which may be used with the present invention, either as a thermoplastic or non-thermoplastic, are polyethylene glycol (PEG)-copolymers and D,L-lactide-co-glycolide polyesters. Some semi-crystalline materials are particularly suitable for surgical bonding and/or staking, especially vibratory bonding and staking Examples of such materials include PAEK (polyaryletherketone), PEEK (polyetheretherketone) and PEKK (polyetherketoneketone). Metals include stainless steel, shape metal alloys, tantalum, porous tantalum, titanium, and cobalt-chrome alloys. Shape memory alloys may include nitinol (nikel-titanium). Shape memory polymers may include PEEK, PMMA, and thermoset polymers. Thermoset polymers may include polyurethanes, polyethylene terephthalate (PET), polyethyleneoxide (PEO), block copolymers containing polystyrene and poly(1,4-butadiene), and ABA triblock copolymers, for example including poly(2-methyl-2-oxazoline) and polytetrahydrofuran. Ceramic materials (i.e. implants) may include silicon nitride, alumina (aluminum oxide), and zircon (zirconium dioxide). Embodiments may include materials configured to resist growth of bacteria and/or biofilm, for example silicon nitride.
Embodiments may be configured to access any treatment site, for example any portion of the body. Embodiments may be configured to transfer objects and/or materials into and/or from the treatment site. Embodiments may utilize a natural body passage or create a passage. The passage may be created through soft or hard tissue. Embodiments may be partially or entirely flexible, curved, non-linear, bendable, and/or may have shape memory properties or materials, which may allow all or any portion of the system to change in shape. A change in shape may include a change in angle, which may range between about 0-180 degrees. Use of a shape memory material may allow the angle to vary within a range of about 0-180 degrees with a change in temperature and/or by the application of heat. Embodiments may be shaped and/or positioned to access a curved or natural anatomic path through the body. Embodiments may be used in conjunction with any devices or methods disclosed in U.S. Pat. No. 6,814,715, titled “Expandable Cannula”, U.S. Patent Application Publication Nos. 2011/0202123, titled “Anatomic Needle System” and 2011/0224539, titled “Methods for Positioning an Ultrasonic Catheter”, and U.S. patent application Ser. No. 13/683,847, titled “Expandable Access Systems and Methods”, all of which are hereby incorporated by reference in their entirety.
The methods and devices disclosed herein may be used in conjunction with any medical procedure. Embodiments may be used before, during, or after a procedure. Treatment areas may include any cavity, vessel, duct, passage, joint, bone, muscle, ligament, tendon, cartilage, capsule, organ, skin, nerve, or other body parts. Embodiments may be used for applications related to biliary ducts, bronchi (i.e. cystic fibrosis), kidney stones, bile ducts, sinus ducts, bone cavities, the vasculature, and any other site in the body. As further examples, embodiments herein may be used in or in conjunction with other medical instruments during sinuplasty, lithotripsy, intervertebral disc surgery, kyphoplasty, knee surgery, hip surgery, organ transplant surgery, bariatric surgery, spinal surgery, anterior cruciate ligament (ACL) surgery, tendon-ligament surgery, rotator cuff surgery, capsule repair surgery, fractured bone surgery, pelvic fracture surgery, avulsion fragment surgery, shoulder surgery, hernia repair surgery, and surgery of an intrasubstance ligament tear, annulus fibrosis, fascia lata, or flexor tendons. Treatment areas include the ear, prostate, biliary ducts, bronchi (i.e. cystic fibrosis), kidney stones, bile ducts, sinuses (i.e. sinusitis), small or large intestines (i.e. diverticulitis), bone cavities, and/or vasculature. Embodiment may be used in any medical application or body portion disclosed herein, disclosed in the incorporated references, or known in the art.
Embodiments may be configured to be used in conjunction with other medical instruments or implants. Embodiments may be configured to position and/or prepare the treatment site for another medical instrument or implant. Instruments may include any dilator, trocar, introducer, imaging device, or any other device or material disclosed herein. Implants may include a coronary artery stent, vascular stent, peripheral vascular stent, urinary tract stent, or urethral stent. Implants may include a partial or total knee replacement, hip replacement, shoulder replacement, bone fastener, etc. Objects may include an organ, partial organ grafts, tissue graft material (i.e. autogenic, allogenic, xenogenic, or synthetic), collagen, a malleable implant like a sponge, mesh, bag/sac/pouch, collagen, or gelatin, or a rigid implant made of metal (i.e. porous or nonporous), polymer, composite, or ceramic. Other implants include breast implants, biodegradable plates, porcine or bovine patches, metallic fasteners, compliant bearing for medial compartment of the knee, nucleus pulposus prosthetics, stents, fasteners, sutures, suture anchors, tissue grafts, or tissue scaffolds.
Tissue scaffolds may include any biologic, synthetic, biodegradable, collagen, polymeric and/or biocompatible scaffold. The scaffold may include a collagen matrix configured to receive viable cells of any type. The matrix may be utilized as a support structure for cells. Different types of cells may be placed at various locations in the matrix. The matrix may be positioned relative to any portion of a patient's body, for example all or any portion of a heart, blood vessel, brain, intestine, stomach, adrenal gland, liver, pancreas, bone, skeleton, spinal cord, or any other organ or any soft or hard tissue. The cell types may include progenitor cells which differentiate and proliferate to form cells having desired characteristics, stromal cells which relate to foundation supporting tissue, and mesenchymal cells which relate to connective tissues, blood and blood vessels, and other systems. Fibroblasts may be used in the production of connective tissues. Osteoblasts may be used in the production of hard tissue (i.e. bone). Myoblasts may be used in the production of muscle. Specific cells may be used to provide for growth of tissue having a function associated with the cell, which may include reticular cells, smooth muscle cells, chondrocytes, retinal cells, endothelial cells, fetal cells, stem cells, embryonic cells, adult cells, enzymes, proteins, and/or other cells disclosed herein or known in the art. Once the viable cells have been positioned on the matrix, the result is a replacement tissue (i.e. an organ). Embodiments of the present disclosure may include the additional devices and methods disclosed in U.S. Pat. No. 7,299,805, titled “Scaffold and Method for Implanting Cells”, which is hereby incorporated by reference in its entirety. Embodiments may also include biofilm that is sterilized to allow sterile biofilm to be used as an adhesive for scaffolds or used as a drug release agent.
Referring to the
Base component 102 may include elongate and/or cylindrical body 110 and head portion 108, which may include one, two, or more tabs that may be configured to be positioned on a surface of a body tissue. (
Insert component 104 may be positionable in all or any portion of the passage of base component 102 or into any other embodiment herein. (
Fixation device 100 may include one or more tapers. (
Elongate member 106 may be secured at any point along its length. Elongate member 106 may include a suture, wire, cable, pin, screw, elongate device, fastener, any combination thereof, or any other device disclosed herein. All or any portion of base component 102, insert component 104, and/or elongate member 106 may deform relative to each other, for example, to secure elongate member 106. (
Body portion 110 may be configured to fit inside a passage in body tissue and/or include a cylindrical shape or any other shape disclosed herein. (
Body portion 110 of base component 102 may be centrally located or offset to an end (not shown). (
All or any portion of base component 102 may include a passage. (
Insert component 104 may include a taper and/or a cross-sectional shape that is circular, triangular, square, rectangular, pentagonal, hexagonal, or any other round or polygon. (
Insert component 104 may be a solid structure or include a passage through all or any portion of its length. The passage may be centrally located or offset (not shown). (
In another embodiment, elongate member 106 may run through the passage in base component 102 and/or insert component 104. (
A leading end of insert component 104 may be configured to fit into the tapered passage of base component 102. (
All or any portion of the passage of base component 102 may be stepped. (
Insert component 104 may include head portion 112 and body portion 114. (
Body portion 114 of insert component 104 may be divided into projections that may be interposed by slits. (
The passage of insert component 104 may include a tapered, chamfered, or radiused surface between head portion 112 and body portion 114. (
Another embodiment of insert component 104 may be pressed into base component 102 with or without a passage in head portion 112. (
Additional embodiments of insert component 104 may have various taper angles and threaded areas. (
Base component 102 may have any shape. Base component 102 may have a substantially symmetric or solid head portion 108, for example circular (shown) or any other shape disclosed herein. (
Referring to
To secure tissue 202 and tissue 204 relative to each other, a cutting instrument, for example a cannulated drill device including an inner drill or K-wire disposed in an exterior cutting sleeve, may be urged into and/or through tissues 202 and 204 from a proximal area to a distal area thereby creating a passage. The inner drill or K-wire and exterior cutting sleeve may be interlocked to simultaneously cut through tissues 202 and 204. Alternatively, the inner drill or K-wire may cut through the fragments before or after the outer sleeve cuts through the fragments.
Next, fastener 116 and elongate member 106 may be deployed. The inner k-wire or drill may be removed while the sleeve is positioned through all or any portion of tissues 202 and 204. Fastener 116, for example an anchor, button, deformable fastener, or any other fixation device, may be connected to elongate member 106 then passed through the sleeve to the distal area. Fastener 116 may include a solid, porous, hard, soft, or deformable material or any other material disclosed herein. Fastener 116 may include a metal, plastic, ceramic, woven, biologic, and/or suture material (i.e. polyethylene). Fastener 116 may be of the same material or different than elongate member 106. Fastener 116 may be rigid, flexible, and/or deformable. Fastener 116 may be comprised of a single or one or more components. Fastener 116 may be positioned through the sleeve by pushing fastener 116 with a pushrod or directly urged with a rigid elongate member 106. Fastener 116 may be positioned through all or any portion of the sleeve, tissue 202, tissue 204, and/or soft tissue adjacent tissue 202 and/or 204. Upon positioning of fastener 116, elongate member 106 may be tensioned thereby pulling fastener 116 against the distal area to reduce the fracture. If the fracture is an avulsion fracture with soft tissue attached to a bone fragment, fastener 116 may be positioned through tissues 202, tissue 204, and the soft tissue attached to the tissues 202 and 204. Tensioning elongate member 106 relative to fastener anchor 116 secures tissues 202 and 204 and the attached soft tissue.
Then, proximal portion of elongate member 106 may be secured, for example, with fixation device 100 or with a knot. The sleeve may be removed from the tissues 202 and 204. Base component 102 may be placed over elongate member 106 near the proximal area and urged toward tissue 202. Body portion 110 of base component 102 may be placed into the tissue passage while head portion 108 of base component 102 remains on the surface of tissue 202. Elongate member 106 may be tensioned by the user manually or with a tensioning instrument to keep tissues 202 and 204 compressed. Insert component 104 may be urged into base component 102 while elongate member 106 remains tensioned. After insert component 104 of fixation device 100 is sufficiently secured to base component 102, elongate member 106 may be secured thereby reducing separation of tissues 202 and 204. Any excess length of elongate member material may be cut and/or removed.
With reference to
Fixation device 100 may be used for any medical application. In an embodiment, one or more fixation device 100 may be used to repair tissue 200 of a femur, for example a lesser trochanter fracture. (
As another embodiment, one or more fixation device 100 may be used to repair a fracture of tissue 200, for example a greater trochanter fracture of the femur. (
In a further embodiment, one or more fixation device 100 may be used to repair an avulsion fracture of tissue 200, for example a greater tuberosity of the humerus. (
Elongate member 106 may be positioned through a straight or curved passage. Elongate member 106 may be positioned through tissue 202, 204, and/or 206, for example, through the humerus and/or greater tuberosity fracture. (
In another embodiment, clamp 300 may be configured to align and reduce the fracture of tissue 200 to drill through the tissue 202 and 204, for example bone fragments. (
Fixation device 100, elongate member 106, and/or fastener 116 may be used in conjunction with other implants, for example implant 122 and/or screw 124. Implant 122 may include an intramedullary rod or nail. Implant 122 may be positioned at any location in the body, for example, to repair a fracture of the proximal femur. (
Embodiments may include two or more sets of fasteners 116, elongate members 106, and/or fixation devices 100 in conjunction with implant 122. (
Embodiments may include introducer 400, for example an awl. (
Fastener 116 may be releasably attached to introducer 400. (
Introducer 400 may include pushrod 406. (
Fastener 116 may include flexible, bendable, and/or deformable configurations for securing elongate member 106. (
Elongate member 106 may be positioned through fastener 116 in a limitless number of configurations. Elongate member 106 may pass through fastener 116 with any number of piercing locations, for example one (not shown), two (
Embodiments may include interlocking components 126, 128, and 130. (
Additional interlocking embodiments are contemplated herein. (
Further interlocking embodiments may include smooth surfaces or attachment features to facilitate locking, for example threaded (shown), textured, roughed, and/or ribbed surfaces. (
Interlocking embodiments may also utilize various shapes or materials and/or combine one or more other embodiments disclosed herein. (
Embodiments may be used in conjunction with joint replacement 500. (
Further embodiments may be configured to repair tissue 200 of articular surfaces of the body, for example articular cartilage. (
Embodiments may be configured to repair a defect in a passage with implant 132. (
Additional embodiments may include clamp 300 and/or be configured for reduction of a fracture in conjunction with insertion of the fastener 116, elongate member 106, and fixation device 100. (
Clamp 300 may be positionable around and configured to secure a fracture of tissue 200. (
Clamp 300 may include drill guide 330 and/or drill assembly 340. (
Then, fastener 116 attached to the elongate member 106 may be positioned (
Fixation device 100 including base component 102 and insert component 104 may be positioned with respect to elongate member 106. (
Clamp 300 may be used in conjunction with instrument 360. (
After instrument 360 is positioned and base bracket 362 is secured, press handle 390 may be adjusted to a desired height by rotating press handle 390 so that handle pin 394 may be moved through slots 374 in uprights 370 and into at least one of positioning holes 376. Handle pin 394 may be generally round with flats on two or more sides, for example, to allow it to be moved from positioning hole 376 and into the slot 374 in uprights 370. From slot 374, handle pin 394 may be rotated into alignment with the desired positioning hole 376. Then, handle pin 394 may be passed into the positioning hole 376, thereby locking the position of the press handle 390.
Elongate member 106 which is passed through the holder tube 356 and into a groove in insert rod 358. Insert rod 358 may be passed through the slot 392 in press handle 390 and into slot 382 in tensioning rod 380. After positioning elongate member 106, elongate member 106 may be held in tension until the tensioning rod 380 is rotated by knob 384. As knob 384 is rotated, tension may be applied to elongate member 106 to pull fastener 116 tight to secure tissue 204 of the fracture of tissue 200. Embodiments may include a tensioning mechanism, for example a clutch, ratchet, gear and pawl, spring loaded lock, anti-reversing mechanism, or any other device disclosed herein capable of holding or applying tension. The tensioning mechanism may be integrated into any portion of the device, for example tensioning rod 380, uprights 370, knob 384, and/or knob connection 386. The tensioning mechanism may be configured to apply tension and/or resist a loss of tension in the elongate member 106. The tensioning mechanism may be configured to dial in or pre-set the desired amount of tension for elongate member 106. Embodiments of the present disclosure may include any additional devices and methods disclosed U.S. Patent Application Publication Nos. 2006/0229623, titled “Tissue Fixation System and Method”, 2008/0195145, titled “Tissue Fixation System and Method”, and 2007/0088362, titled “Apparatus and Methods for Surgery”, which are hereby incorporated by reference in their entirety.
After elongate member 106 is tensioned to reduce the fracture, press handle 390 may be squeezed and rotated toward the handle 310. This motion may drive insert rod 358 toward tissue 200, thereby pressing insert component 104 into the base component 102 and/or securing elongate member 106. After the press handle 390 is rotated, the pressure on handle 390 may be released, elongate member 106 in the tensioning rod 380 may be unwrapped or cut, and instrument 360 may be removed. After insert component 104 is pressed into the base component 102 with the elongate member 106 captured therein, insert rod 358 and holder tube 356 can be removed, thereby leaving the fixation device 100 on a proximal area of the tissue 202, fastener 116 on a distal area of tissue 204, and elongate member 106 tensioned and secured therebetween.
In addition to the embodiments of
As another embodiment, fixation device 100 may include a threaded insert component 104 configured to screw into threaded base component 102 to secure the elongate member 106. (
Insert 104 may also be threaded at a taper angle that may or may not match a threaded taper of the base component 102. (
Another embodiment of fixation device 100 may include a tortuous path to secure elongate member 106. (
Additional embodiments of fixation device 100 may include insert component 104 that may be configured to be driven into the base component 102 with energy, for example vibratory (i.e. ultrasonic) or thermal energy. (
Embodiments may use energy to bond, assemble, secure, and/or position fixation devices and/or implants. Energy may be applied preoperatively, intraoperatively, or postoperatively. For example, vibratory energy (i.e. ultrasonic energy) may be utilized to bond fixation devices and/or implants (i.e. joint replacements) with respect to a portion of the body. Vibratory energy may be utilized to bond one or more components of the embodiments herein with respect to each other. Embodiments of the present disclosure may include any additional devices and methods disclosed in any of U.S. Pat. No. 7,967,820, titled “Methods and Devices for Trauma Welding” and U.S. Pat. No. 8,162,977, titled “Methods for Joining Implants”, U.S. Patent Application Publication Nos. 2009/0024161, titled “Methods and Devices for Intracorporeal Bonding of Implants with Thermal Energy”, 2010/0211120, titled “Methods and Devices for Utilizing Bondable Materials”, 2012/0316472, titled “Ultrasonic Handpiece”, 2012/0316473, titled “Methods and Systems for Controlling an Ultrasonic Handpiece based on a Sensed Pressure”, 2012/0316474, “Methods and Systems for Controlling an Ultrasonic Handpiece based on Tuning Signals”, and U.S. patent application Ser. No. 13/789,658, titled “Vibratory Energy Systems and Methods for Occluded Body Cavities”, all of which are hereby incorporated by reference in their entirety.
Embodiments may include with a shape memory material. (
Further embodiments may include deformable materials or configurations. (
Additional embodiments may be utilized with implants, for example plates and/or screws. (
All or any portion of implant 122 may include attachment features. (
Implants may include screw 124. Screw 124 may include holes 136 configured to receive fastener 116, elongate member 106, fixation device 100, and/or insert component 104. (
Embodiments may include scaffold or mesh 132. (
In addition, embodiments may be configured for vascular anastomotic repair. Two tissue segments may be reattached to each other, for example over bone or using a scalpel or balloon. Tissue segments may include tubular, vessel, or anastomotic segments. For example, if an expandable device (i.e. an inflatable device such as a balloon) is positioned to hold the two anastomotic segments in apposition while maintaining the inner diameter, a curved introducer (i.e. awl) may place fastener 116 in a curved section across one vessel segment pulling it around the expandable device or around the scalpel in a curved path back to the second vessel segment, thereby allowing this procedure to tighten and maintain the internal dimension while the expandable device and scalpel are in position. The expandable device (i.e. balloon) may be deflated and the scalpel removed, for example, so the repair occurs around this. Embodiments may be reinforced or sealed with glue adhesive, biofilm adhesive, type adhesive, or any other method disclosed herein. The expandable device and scalpel may maintain the internal dimensions while the outer repair is performed. Embodiments herein may be used in conjunction with the devices and methods disclosed in U.S. Pat. No. 7,497,864, title “Tissue fastener and methods for using same”, which is hereby incorporated by reference in its entirety.
Embodiments may be configured for guidance and/or positioning with energy, for example magnetic energy. Embodiments may include a magnet, electromagnet, and/or magnetizable materials, for example, to position the embodiments herein with a magnetic field. Magnetizable materials include ferrite particles, which may or may not be magnetized. The electromagnet may selectively provide a magnetic field with application of current. The magnetic field may emanate from any portion of the embodiments herein. The magnet, electromagnet, and/or magnetizable materials may be mounted on or included in all or any portion of the embodiments herein. A leading end portion may be utilized to position and/or guide the system. The magnetic field may emanate from a portion of the system or from an external source positioned outside the body. The polarity and/or strength of the magnetic field may be increased, decreased, or alternated to controllably guide the system, for example effector 110. Embodiments of the present disclosure may also include any devices and methods disclosed in U.S. Pat. No. 7,320,319, titled “Medicant Delivery System and Method”, U.S. Patent Application Publication No. 2008/0306324, titled “Magnetic Joint Implant”, and U.S. Pat. No. 6,719,765, titled “Magnetic Suturing System and Method”, which are hereby incorporated by reference in their entirety
Further embodiments may include a robotic system. The robotic system may position fixation devices, for example, by driving them with navigation or imaging devices (i.e. arthroscopic visualization). The robotic system may be configured for repair of tissue fragments. Embodiments may include a robotic arm. The robotic arm may include a robotic mechanism. Embodiments may be configured to position and/or guide any portion of the system. The robotic arm may include a haptic arm. The robotic arm may be automatic, programmed, user controlled, and/or remote controlled. The motion path of the robotic arm may include end points or boundaries, for example, to minimize user error. Embodiments of the present disclosure may also include any devices and methods disclosed in U.S. Patent Application Publication Nos. 2003/0181800, titled “Methods of Securing Body Tissue”, and 2012/0221017, titled “Methods for Robotic Arthroplasty”, which are hereby incorporated by reference in their entirety.
Embodiments may also be positioned with an imaging or guidance device. Imaging devices may be used to directly or indirectly visualize, guide and/or change the orientation or position of embodiments herein. Examples of imaging devices may include endoscopic guidance, computer assisted navigation, magnetic resonance imaging (MRI), CT scan, ultrasound, fluoroscopic, cystoscopy, endoscopic retrograde cholangiopancreatography cystoscopy (ERCP), X-ray, light detectors, metal detectors, magnetic field detectors, electromagnetic devices, or other visualization device disclosed herein. Asymmetric coating, radiopaque markers, or other features identifiable with indirect visualization may be used to identify and/or adjust orientation or position. Indirect visualization may also be used to align portions of a first device relative to a portion of the first device, a second device, or a body portion.
Additional embodiments may be configured to secure and/or stabilize the spine. For example, embodiments may be configured to repair an intervertebral disc herniation. Fixation devices 100, fastener 116, and/or elongate member 106 may be configured to move the disk herniation and repair the annulus. Elongate member 106 may be configured to secure two or more fasteners, rods, or plates relative to each other. Embodiments may be configured to repair soft tissues (i.e. ligaments) to hard tissues (i.e. bone) or be used in conjunction with any other tissues or implants disclosed herein. Embodiments of the present disclosure may include any additional devices and methods disclosed U.S. Patent Application Publication No. 2006/0089646, titled “Devices and Methods for Stabilizing Tissue and Implants”, which is hereby incorporated by reference in its entirety.
Any embodiment herein may be secured using any of the features or methods disclosed herein. For example, base component 102 and insert component 104 may be secured with any internal and/or external attachment features or methods disclosed herein or known in the art. As another example, fixation devices may be integrated into a portion of a plate, independent of a plate, a portion of an implant, screw, or rod. Embodiments may be secured preoperatively, intraoperatively, or postoperatively. Embodiments may be secured with ultrasonic energy, thermal energy, radiofrequency energy, expandable or hydrophilic materials, chemical, electrical, pressure, press-fit, tapered surfaces, threaded surfaces, mechanical or non-mechanical interlocks, or any other attachment feature disclosed herein. Two or more components may be secured with an expandable ring configured to lock two or more components together.
Embodiments may have any material disclosed herein. Embodiments may be all or partially biodegradable. Embodiments may be configured with a portion being a more rigid polymer and another portion being a less rigid polymer. Any portions may be configured to adhere or stick together to resist movement of elongate member 106 (i.e. suture). Embodiments may be configured to allow elongate member 106 to slide when pulled in one direction while resisting motion or disengage elongate member 106 by pulling in the opposite direction. Embodiments may be configured with two components of a similar material but with a different modulus of elasticity, for example to secure elongate member 106 when urged together and to allow elongate member 106 to move when pulled in a first direction but not in a second direction.
One, two or more elongate members 106 may be positioned through an implant, for example a plate, screw, rod, or arthroplasty component. Embodiments may include an angled or flexible configuration. Embodiments may include a curved, smooth, or tapered edge, for example to facilitate introduction and/or minimize soft tissue damage. Embodiments may be introduced in a linear configuration and/or positioned in a non-linear or bent configuration. The implant may have attachment features (i.e. holes) specifically sized and configured for fixation devices. The attachment feature may be recessed and/or adjacent to a plate or rod so the system may be used with traditional screws. To receive a fixation device or elongate member, the attachment feature may be smaller than holes required for traditional screws. This may preserve the mechanical integrity of a plate, screw, or rod, provide improved fixation, and/or allow for fixation to and/or from varying, curved, or nonlinear paths with respect to plates, screw, rods, or other implants. Embodiments may be used to fasten an implant to hard tissue (i.e. bone) or soft tissue to an implant, for example if a ligament is pulled away from a hip or knee implant. As another example, embodiments may be used for reattachment of greater trochanteric tendons. In addition, embodiments of the present disclosure may include all or any portion of the embodiments disclosed in U.S. Pat. No. 7,837,736, titled “Minimally Invasive Surgical Systems and Methods”, which is incorporated herein by reference in its entirety.
All or any portion of any embodiment herein may include any combination of the embodiments disclosed herein. This written description uses examples to disclose various embodiments, which include the best mode, to enable any person skilled in the art to practice those embodiments, including making and using any devices or systems and performing any incorporated methods. The patentable scope is defined by the claims, and may include other examples that occur to those skilled in the art. Such other examples are intended to be within the scope of the claims if they have structural elements that do not differ from the literal language of the claims, or if they include equivalent structural elements with insubstantial differences from the literal languages of the claims.
This non-provisional application is based on and claims priority to U.S. Provisional Application No. 61/749,261 filed Jan. 5, 2013, titled “FIXATION DEVICES AND METHODS”, the entire contents of which are hereby expressly incorporated by reference into this disclosure as if set forth fully herein.
Number | Name | Date | Kind |
---|---|---|---|
319296 | Molesworth | Jun 1885 | A |
668878 | Jensen | Feb 1901 | A |
668879 | Miller | Feb 1901 | A |
702789 | Gibson | Jun 1902 | A |
862712 | Collins | Aug 1907 | A |
2121193 | Hanicke | Dec 1932 | A |
2187852 | Friddle | Aug 1936 | A |
2178840 | Lorenian | Nov 1939 | A |
2199025 | Conn | Apr 1940 | A |
2235419 | Callahan | Mar 1941 | A |
2248054 | Becker | Jul 1941 | A |
2270188 | Longfellow | Jan 1942 | A |
2518276 | Braward | Aug 1950 | A |
2557669 | Lloyd | Jun 1951 | A |
2566499 | Richter | Sep 1951 | A |
2621653 | Briggs | Dec 1952 | A |
2725053 | Bambara | Nov 1955 | A |
2830587 | Everett | Apr 1958 | A |
3204635 | Voss et al. | Sep 1965 | A |
3311110 | Singerman | Mar 1967 | A |
3347234 | Voss | Oct 1967 | A |
3367809 | Soloff | Feb 1968 | A |
3391690 | Armao | Jul 1968 | A |
3477429 | Sampson | Nov 1969 | A |
3513848 | Winston et al. | May 1970 | A |
3518993 | Blake | Jul 1970 | A |
3577991 | Wilkinson | May 1971 | A |
3596292 | Erb et al. | Aug 1971 | A |
3608539 | Miller | Sep 1971 | A |
3625220 | Engelsher | Dec 1971 | A |
3648705 | Lary | Mar 1972 | A |
3653388 | Tenckhoff | Apr 1972 | A |
3656476 | Swinney | Apr 1972 | A |
3657056 | Winston et al. | Apr 1972 | A |
3678980 | Gutshall | Jul 1972 | A |
3709218 | Halloran | Jan 1973 | A |
3711347 | Wagner et al. | Jan 1973 | A |
3760808 | Bleuer | Sep 1973 | A |
3788318 | Kim et al. | Jan 1974 | A |
3789852 | Kim et al. | Feb 1974 | A |
3802438 | Wolvek | Apr 1974 | A |
3807394 | Attenborough | Apr 1974 | A |
3809075 | Matles | May 1974 | A |
3811449 | Gravlee et al. | May 1974 | A |
3825010 | McDonald | Jul 1974 | A |
3833003 | Taricco | Sep 1974 | A |
3835849 | McGuire | Sep 1974 | A |
3842824 | Neufeld | Oct 1974 | A |
3857396 | Hardwick | Dec 1974 | A |
3867932 | Huene | Feb 1975 | A |
3875652 | Arnold | Apr 1975 | A |
3898992 | Balamuth | Aug 1975 | A |
3918442 | Nikolaev et al. | Nov 1975 | A |
3968800 | Vilasi | Jul 1976 | A |
4023559 | Gaskell | May 1977 | A |
4064566 | Fletcher et al. | Dec 1977 | A |
4089071 | Kainberz et al. | May 1978 | A |
4156574 | Boben | May 1979 | A |
4164794 | Spector et al. | Aug 1979 | A |
4171544 | Hench et al. | Oct 1979 | A |
4183102 | Guiset | Jan 1980 | A |
4199864 | Ashman | Apr 1980 | A |
4200939 | Oser | May 1980 | A |
4210148 | Stivala | Jul 1980 | A |
4213816 | Morris | Jul 1980 | A |
4235233 | Mouwen | Nov 1980 | A |
4235238 | Ogiu et al. | Nov 1980 | A |
4257411 | Cho | Mar 1981 | A |
4265231 | Scheller, Jr. et al. | May 1981 | A |
4281649 | Derweduwen | Aug 1981 | A |
4291698 | Fuchs | Sep 1981 | A |
4309488 | Heide et al. | Jan 1982 | A |
4320762 | Bentov | Mar 1982 | A |
4351069 | Ballintyn et al. | Sep 1982 | A |
4364381 | Sher et al. | Dec 1982 | A |
4365356 | Broemer et al. | Dec 1982 | A |
4388921 | Sutter et al. | Jun 1983 | A |
4395798 | McVey | Aug 1983 | A |
4409974 | Freedland | Oct 1983 | A |
4414166 | Charlson et al. | Nov 1983 | A |
4437191 | Van der Zat et al. | Mar 1984 | A |
4437362 | Hurst | Mar 1984 | A |
4444180 | Schneider et al. | Apr 1984 | A |
4448194 | DiGiovanni et al. | May 1984 | A |
4456005 | Lichty | Jun 1984 | A |
4461281 | Carson | Jul 1984 | A |
4484570 | Sutter et al. | Nov 1984 | A |
4493317 | Klaue | Jan 1985 | A |
4495664 | Bianquaert | Jan 1985 | A |
4501031 | McDaniel et al. | Feb 1985 | A |
4504268 | Herlitze | Mar 1985 | A |
4506681 | Mundell | Mar 1985 | A |
4514125 | Stol | Apr 1985 | A |
4526173 | Sheehan | Jul 1985 | A |
4532926 | O'Holla | Aug 1985 | A |
4535772 | Sheehan | Aug 1985 | A |
4547327 | Bruins et al. | Oct 1985 | A |
4556350 | Bernhardt et al. | Dec 1985 | A |
4566138 | Lewis et al. | Jan 1986 | A |
4589868 | Dretler | May 1986 | A |
4590928 | Hunt et al. | May 1986 | A |
4597379 | Kihn et al. | Jul 1986 | A |
4599085 | Riess et al. | Jul 1986 | A |
4601893 | Cardinal | Jul 1986 | A |
4606335 | Wedeen | Aug 1986 | A |
4621640 | Mulhollan et al. | Nov 1986 | A |
4630609 | Chin | Dec 1986 | A |
4632100 | Somers | Dec 1986 | A |
4632101 | Freedland | Dec 1986 | A |
4645503 | Lin et al. | Feb 1987 | A |
4657460 | Bien | Apr 1987 | A |
4659268 | Del Mundo et al. | Apr 1987 | A |
4662063 | Collins et al. | May 1987 | A |
4662068 | Polonsky | May 1987 | A |
4662887 | Turner et al. | May 1987 | A |
4669473 | Richards et al. | Jun 1987 | A |
4685458 | Leckrone | Aug 1987 | A |
4691741 | Affa | Sep 1987 | A |
4705040 | Mueller et al. | Nov 1987 | A |
4706670 | Andersen et al. | Nov 1987 | A |
4708139 | Dunbar, IV | Nov 1987 | A |
4713077 | Small | Dec 1987 | A |
4716901 | Jackson et al. | Jan 1988 | A |
4718909 | Brown | Jan 1988 | A |
4722331 | Fox | Feb 1988 | A |
4722948 | Sanderson | Feb 1988 | A |
4724584 | Kasai | Feb 1988 | A |
4738255 | Goble et al. | Apr 1988 | A |
4739751 | Sapega et al. | Apr 1988 | A |
4741330 | Hayhurst | May 1988 | A |
4743257 | Tormala | May 1988 | A |
4749585 | Greco et al. | Jun 1988 | A |
4750492 | Jacobs | Jun 1988 | A |
4768507 | Fischell | Sep 1988 | A |
4772286 | Goble et al. | Sep 1988 | A |
4776328 | Frey et al. | Oct 1988 | A |
4776738 | Winston | Oct 1988 | A |
4776851 | Bruchman et al. | Oct 1988 | A |
4781182 | Purnell et al. | Nov 1988 | A |
4790303 | Steffee | Dec 1988 | A |
4792336 | Hiavacek et al. | Dec 1988 | A |
4817591 | Klause | Apr 1989 | A |
4822224 | Carl et al. | Apr 1989 | A |
4823794 | Pierce | Apr 1989 | A |
4832025 | Coates | May 1989 | A |
4832026 | Jones | May 1989 | A |
4834752 | Van Kampen | May 1989 | A |
4841960 | Garner | Jun 1989 | A |
4843112 | Gerhart | Jun 1989 | A |
4846812 | Walker et al. | Jul 1989 | A |
4862882 | Venturi et al. | Sep 1989 | A |
4869242 | Galluzzo | Sep 1989 | A |
4870957 | Goble et al. | Oct 1989 | A |
4883048 | Purnell et al. | Nov 1989 | A |
4890612 | Kensey | Jan 1990 | A |
4895148 | Bays et al. | Jan 1990 | A |
4898156 | Gatturna et al. | Feb 1990 | A |
4899729 | Gill et al. | Feb 1990 | A |
4899744 | Fujitsuka et al. | Feb 1990 | A |
4901721 | Hakki | Feb 1990 | A |
4921479 | Grayzel | May 1990 | A |
4922897 | Sapega et al. | May 1990 | A |
4924866 | Yoon | May 1990 | A |
4932960 | Green et al. | Jun 1990 | A |
4935026 | Drews | Jun 1990 | A |
4935028 | Drews | Jun 1990 | A |
4945625 | Winston | Aug 1990 | A |
4946468 | Li | Aug 1990 | A |
4950285 | Wilk | Aug 1990 | A |
4954126 | Wallsten | Sep 1990 | A |
4955910 | Bolesky | Sep 1990 | A |
4957498 | Caspari et al. | Sep 1990 | A |
4961741 | Hayhurst | Oct 1990 | A |
4963151 | Ducheyne et al. | Oct 1990 | A |
4966583 | Debbas | Oct 1990 | A |
4968315 | Gatturna | Nov 1990 | A |
4968317 | Tormala | Nov 1990 | A |
4969888 | Scholten et al. | Nov 1990 | A |
4969892 | Burton et al. | Nov 1990 | A |
4990161 | Kampner | Feb 1991 | A |
4994071 | MacGregor | Feb 1991 | A |
4997445 | Hodorek | Mar 1991 | A |
4998539 | Delsanti | Mar 1991 | A |
5002550 | Li | Mar 1991 | A |
5002563 | Pyka et al. | Mar 1991 | A |
5009652 | Morgan et al. | Apr 1991 | A |
5009663 | Broome | Apr 1991 | A |
5009664 | Sievers | Apr 1991 | A |
5013316 | Goble et al. | May 1991 | A |
5019090 | Pinchuk | May 1991 | A |
5021059 | Kensey et al. | Jun 1991 | A |
5035713 | Friis | Jul 1991 | A |
5037404 | Gold et al. | Aug 1991 | A |
5037422 | Hayhurst et al. | Aug 1991 | A |
5041093 | Chu | Aug 1991 | A |
5041114 | Chapman et al. | Aug 1991 | A |
5041129 | Hayhurst et al. | Aug 1991 | A |
5046513 | Gatturna et al. | Sep 1991 | A |
5047055 | Bao et al. | Sep 1991 | A |
5051049 | Wills | Sep 1991 | A |
5053046 | Janese | Oct 1991 | A |
5053047 | Yoon | Oct 1991 | A |
5059193 | Kuslich | Oct 1991 | A |
5059206 | Winters | Oct 1991 | A |
5061274 | Kensey | Oct 1991 | A |
5061286 | Lyle | Oct 1991 | A |
5064286 | Lyle | Oct 1991 | A |
5069674 | Fearnot et al. | Dec 1991 | A |
5078731 | Hayhurst | Jan 1992 | A |
5078744 | Chvapil | Jan 1992 | A |
5078745 | Rhenter et al. | Jan 1992 | A |
5084050 | Draenert | Jan 1992 | A |
5084051 | Tormala et al. | Jan 1992 | A |
5085660 | Lin | Feb 1992 | A |
5085661 | Moss | Feb 1992 | A |
5098433 | Freedland | Mar 1992 | A |
5098434 | Serbousek | Mar 1992 | A |
5098436 | Ferrante et al. | Mar 1992 | A |
5100405 | McLaren | Mar 1992 | A |
5100417 | Cerier et al. | Mar 1992 | A |
5102417 | Palmaz | Apr 1992 | A |
5102421 | Anspach, Jr. | Apr 1992 | A |
5108399 | Eitenmuller et al. | Apr 1992 | A |
5120175 | Arbegast et al. | Jun 1992 | A |
5123520 | Schmid et al. | Jun 1992 | A |
5123914 | Cope | Jun 1992 | A |
5123941 | Lauren et al. | Jun 1992 | A |
5133732 | Wiktor | Jul 1992 | A |
RE34021 | Mueller | Aug 1992 | E |
5141520 | Goble et al. | Aug 1992 | A |
5147362 | Goble | Sep 1992 | A |
5154720 | Trott et al. | Oct 1992 | A |
5156613 | Sawyer | Oct 1992 | A |
5156616 | Meadows et al. | Oct 1992 | A |
5158566 | Pianetti | Oct 1992 | A |
5158934 | Ammann et al. | Oct 1992 | A |
5163960 | Bonutti | Nov 1992 | A |
5171251 | Bregen et al. | Dec 1992 | A |
5176682 | Chow | Jan 1993 | A |
5179964 | Cook | Jan 1993 | A |
5180385 | Sontag | Jan 1993 | A |
5180388 | DiCarlo | Jan 1993 | A |
5183464 | Dubrul et al. | Feb 1993 | A |
5192287 | Fournier et al. | Mar 1993 | A |
5192326 | Bao et al. | Mar 1993 | A |
5197166 | Meier et al. | Mar 1993 | A |
5197971 | Bonutti | Mar 1993 | A |
5203784 | Ross et al. | Apr 1993 | A |
5203787 | Noblitt | Apr 1993 | A |
5208950 | Merritt | May 1993 | A |
5209776 | Bass et al. | May 1993 | A |
5217493 | Raad et al. | Jun 1993 | A |
5219359 | McQuilkin et al. | Jun 1993 | A |
5226899 | Lee et al. | Jul 1993 | A |
5234006 | Eaton et al. | Aug 1993 | A |
5234425 | Fogarty et al. | Aug 1993 | A |
5234443 | Phan | Aug 1993 | A |
5236438 | Wilk | Aug 1993 | A |
5236445 | Hayhurst | Aug 1993 | A |
5242902 | Murphy et al. | Sep 1993 | A |
5254113 | Wilk | Oct 1993 | A |
5258007 | Spetzler et al. | Nov 1993 | A |
5258015 | Li et al. | Nov 1993 | A |
5258016 | DiPoto et al. | Nov 1993 | A |
5261886 | Chesterfield | Nov 1993 | A |
5266325 | Kuzma et al. | Nov 1993 | A |
5269783 | Sander | Dec 1993 | A |
5269785 | Bonutti | Dec 1993 | A |
5269809 | Hayhurst et al. | Dec 1993 | A |
5281235 | Haber et al. | Jan 1994 | A |
5282832 | Toso et al. | Feb 1994 | A |
5290281 | Tschakaloff | Mar 1994 | A |
5304119 | Balaban et al. | Apr 1994 | A |
5306280 | Bregen et al. | Apr 1994 | A |
5306301 | Graf et al. | Apr 1994 | A |
5315741 | Dubberke | May 1994 | A |
5318588 | Horzewski et al. | Jun 1994 | A |
5320611 | Bonutti et al. | Jun 1994 | A |
5324308 | Pierce | Jun 1994 | A |
5328480 | Melker et al. | Jul 1994 | A |
5329846 | Bonutti | Jul 1994 | A |
5329924 | Bonutti | Jul 1994 | A |
5330468 | Burkhart | Jul 1994 | A |
5330476 | Hiot et al. | Jul 1994 | A |
5330486 | Wilk | Jul 1994 | A |
5336231 | Adair | Aug 1994 | A |
5336240 | Metzler et al. | Aug 1994 | A |
5339799 | Kami et al. | Aug 1994 | A |
5349956 | Bonutti | Sep 1994 | A |
5352229 | Goble et al. | Oct 1994 | A |
5354298 | Lee et al. | Oct 1994 | A |
5354302 | Ko | Oct 1994 | A |
5366480 | Corriveaau et al. | Nov 1994 | A |
5370646 | Reese et al. | Dec 1994 | A |
5370660 | Weinstein et al. | Dec 1994 | A |
5372146 | Branch | Dec 1994 | A |
5374235 | Ahrens | Dec 1994 | A |
5376126 | Lin | Dec 1994 | A |
5382254 | McGarry et al. | Jan 1995 | A |
5383883 | Wilk et al. | Jan 1995 | A |
5383905 | Golds et al. | Jan 1995 | A |
5391173 | Wilk | Feb 1995 | A |
5395308 | Fox et al. | Mar 1995 | A |
5397311 | Walker et al. | Mar 1995 | A |
5400805 | Warren | Mar 1995 | A |
5403312 | Yates et al. | Apr 1995 | A |
5403348 | Bonutti | Apr 1995 | A |
5405359 | Pierce | Apr 1995 | A |
5411523 | Goble | May 1995 | A |
5413585 | Pagedas | May 1995 | A |
5417691 | Hayhurst | May 1995 | A |
5417701 | Holmes | May 1995 | A |
5417712 | Whittaker et al. | May 1995 | A |
5423796 | Shikhman et al. | Jun 1995 | A |
5431670 | Holmes | Jul 1995 | A |
5439470 | Li | Aug 1995 | A |
5441538 | Bonutti | Aug 1995 | A |
5443512 | Parr et al. | Aug 1995 | A |
5447503 | Miller | Sep 1995 | A |
5449372 | Schmaltz et al. | Sep 1995 | A |
5449382 | Dayton | Sep 1995 | A |
5451235 | Lock | Sep 1995 | A |
5453090 | Martinez et al. | Sep 1995 | A |
5456722 | McLeod et al. | Oct 1995 | A |
5458653 | Davison | Oct 1995 | A |
5462561 | Voda | Oct 1995 | A |
5464424 | O'Don | Nov 1995 | A |
5464426 | Bonutti | Nov 1995 | A |
5464427 | Curtis et al. | Nov 1995 | A |
5470337 | Moss | Nov 1995 | A |
5472444 | Huebner et al. | Dec 1995 | A |
5474554 | Ku | Dec 1995 | A |
5478351 | Meade et al. | Dec 1995 | A |
5478353 | Yoon | Dec 1995 | A |
5480403 | Lee et al. | Jan 1996 | A |
5486197 | Le et al. | Jan 1996 | A |
5487844 | Fujita | Jan 1996 | A |
5488958 | Topel et al. | Feb 1996 | A |
5496292 | Burnham | Mar 1996 | A |
5496318 | Howland | Mar 1996 | A |
5496335 | Thomason et al. | Mar 1996 | A |
5496348 | Bonutti | Mar 1996 | A |
5500000 | Feagin et al. | Mar 1996 | A |
5501700 | Hirata | Mar 1996 | A |
5504977 | Weppner | Apr 1996 | A |
5505735 | Li | Apr 1996 | A |
5507754 | Green et al. | Apr 1996 | A |
5522844 | Johnson | Jun 1996 | A |
5522845 | Wenstrom, Jr. | Jun 1996 | A |
5522846 | Bonutti | Jun 1996 | A |
5527341 | Gogolewski et al. | Jun 1996 | A |
5527342 | Pietrzak et al. | Jun 1996 | A |
5527343 | Bonutti | Jun 1996 | A |
5529075 | Clark | Jun 1996 | A |
5531759 | Kensey et al. | Jul 1996 | A |
5534012 | Bonutti | Jul 1996 | A |
5534028 | Bao et al. | Jul 1996 | A |
5540718 | Bartlett | Jul 1996 | A |
5542423 | Bonutti | Aug 1996 | A |
5545178 | Kensey et al. | Aug 1996 | A |
5545180 | Le et al. | Aug 1996 | A |
5545206 | Carson | Aug 1996 | A |
5549630 | Bonutti | Aug 1996 | A |
5549631 | Bonutti | Aug 1996 | A |
5556402 | Xu | Sep 1996 | A |
5569252 | Justin et al. | Oct 1996 | A |
5569305 | Bonutti | Oct 1996 | A |
5569306 | Thal | Oct 1996 | A |
5573517 | Bonutti et al. | Nov 1996 | A |
5573538 | Laboureau | Nov 1996 | A |
5573542 | Stevens | Nov 1996 | A |
5575801 | Habermeyer | Nov 1996 | A |
5578046 | Liu | Nov 1996 | A |
5580344 | Hasson | Dec 1996 | A |
5584835 | Greenfield | Dec 1996 | A |
5584839 | Gieringer | Dec 1996 | A |
5584860 | Goble et al. | Dec 1996 | A |
5584862 | Bonutti | Dec 1996 | A |
5591206 | Moufarrege | Jan 1997 | A |
5593422 | Muijs Van De Moer et al. | Jan 1997 | A |
5593425 | Bonutti et al. | Jan 1997 | A |
5593625 | Riebel et al. | Jan 1997 | A |
5601557 | Hayhurst | Feb 1997 | A |
5601558 | Torrie et al. | Feb 1997 | A |
5601595 | Schwartz | Feb 1997 | A |
5607427 | Tschakaloff | Mar 1997 | A |
5609595 | Pennig | Mar 1997 | A |
5618314 | Harwin et al. | Apr 1997 | A |
5620461 | Muijs Van De Moer et al. | Apr 1997 | A |
5626612 | Bartlett | May 1997 | A |
5626614 | Hart | May 1997 | A |
5626718 | Philippe et al. | May 1997 | A |
5630824 | Hart | May 1997 | A |
5634926 | Jobe | Jun 1997 | A |
5628751 | Sander et al. | Jul 1997 | A |
5643274 | Sander et al. | Jul 1997 | A |
5643293 | Kogasaka et al. | Jul 1997 | A |
5643295 | Yoon | Jul 1997 | A |
5643321 | McDevitt | Jul 1997 | A |
5645553 | Kolesa et al. | Jul 1997 | A |
5645597 | Krapiva | Jul 1997 | A |
5645599 | Samani | Jul 1997 | A |
5649955 | Hashimoto et al. | Jul 1997 | A |
5649963 | McDevitt | Jul 1997 | A |
5651377 | O'Donnell, Jr. | Jul 1997 | A |
5658313 | Thal | Aug 1997 | A |
5660225 | Saffran | Aug 1997 | A |
5662658 | Wenstrom, Jr. | Sep 1997 | A |
5665089 | Dall et al. | Sep 1997 | A |
5665109 | Yoon | Sep 1997 | A |
5667513 | Torrie et al. | Sep 1997 | A |
5669917 | Sauer et al. | Sep 1997 | A |
5674240 | Bonutti | Oct 1997 | A |
5681310 | Yuan et al. | Oct 1997 | A |
5681333 | Burkhart et al. | Oct 1997 | A |
5681351 | Jamiolkowski et al. | Oct 1997 | A |
5681352 | Clancy, III et al. | Oct 1997 | A |
5685820 | Riek et al. | Nov 1997 | A |
5688283 | Knapp | Nov 1997 | A |
5690654 | Ovil | Nov 1997 | A |
5690655 | Hart et al. | Nov 1997 | A |
5690676 | DiPoto et al. | Nov 1997 | A |
5693055 | Zahiri et al. | Dec 1997 | A |
5697950 | Fucci et al. | Dec 1997 | A |
5702397 | Gonle et al. | Dec 1997 | A |
5702462 | Oberlander | Dec 1997 | A |
5707395 | Li | Jan 1998 | A |
5713903 | Sander et al. | Feb 1998 | A |
5713921 | Bonutti | Feb 1998 | A |
5718717 | Bonutti | Feb 1998 | A |
5720747 | Burke | Feb 1998 | A |
5725541 | Anspach, III et al. | Mar 1998 | A |
5725556 | Moser et al. | Mar 1998 | A |
5725582 | Bevan | Mar 1998 | A |
5730747 | Ek et al. | Mar 1998 | A |
5733306 | Bonutti | Mar 1998 | A |
5720753 | Sander et al. | Apr 1998 | A |
5735875 | Bonutti et al. | Apr 1998 | A |
5735877 | Pagedas | Apr 1998 | A |
5735899 | Schwartz et al. | Apr 1998 | A |
5741282 | Anspach, III et al. | Apr 1998 | A |
5752952 | Adamson | May 1998 | A |
5752974 | Rhee et al. | May 1998 | A |
5755809 | Cohen et al. | May 1998 | A |
5762458 | Wang et al. | Jun 1998 | A |
5766221 | Benderev et al. | Jun 1998 | A |
5769894 | Ferragamo | Jun 1998 | A |
5772672 | Toy et al. | Jun 1998 | A |
5776151 | Chan | Jul 1998 | A |
5779706 | Tschakaloff | Jul 1998 | A |
5782862 | Bonutti | Jul 1998 | A |
5785713 | Jobe | Jul 1998 | A |
5792096 | Rentmeester et al. | Aug 1998 | A |
5797931 | Bito et al. | Aug 1998 | A |
5800537 | Bell | Sep 1998 | A |
5807403 | Beyar et al. | Sep 1998 | A |
5810849 | Kontos | Sep 1998 | A |
5810853 | Yoon | Sep 1998 | A |
5810884 | Kim | Sep 1998 | A |
5814072 | Bonutti | Sep 1998 | A |
5814073 | Bonutti | Sep 1998 | A |
5817107 | Schaller | Oct 1998 | A |
5823994 | Sharkey et al. | Oct 1998 | A |
5824009 | Fukuda et al. | Oct 1998 | A |
5830125 | Scribner et al. | Nov 1998 | A |
5836897 | Sakural et al. | Nov 1998 | A |
5839899 | Robinson | Nov 1998 | A |
5843084 | Hart | Dec 1998 | A |
5843178 | Vanney et al. | Dec 1998 | A |
5845645 | Bonutti | Dec 1998 | A |
5851185 | Berns | Dec 1998 | A |
5865834 | McGuire | Feb 1999 | A |
5866634 | Tokushige | Feb 1999 | A |
5868749 | Reed | Feb 1999 | A |
5874235 | Chan | Feb 1999 | A |
5879372 | Bartlett | Mar 1999 | A |
5891166 | Schervinsky | Apr 1999 | A |
5891168 | Thal | Apr 1999 | A |
5893880 | Egan et al. | Apr 1999 | A |
5897574 | Bonutti | Apr 1999 | A |
5899911 | Carter | May 1999 | A |
5899921 | Caspari et al. | May 1999 | A |
5906579 | Vander Salm et al. | May 1999 | A |
5906625 | Bito et al. | May 1999 | A |
5908429 | Yoon | Jun 1999 | A |
5911721 | Nicholson et al. | Jun 1999 | A |
5918604 | Whelan | Jul 1999 | A |
5919193 | Slavitt | Jul 1999 | A |
5919194 | Anderson | Jul 1999 | A |
5919208 | Valenti | Jul 1999 | A |
5919215 | Wiklund et al. | Jul 1999 | A |
5921986 | Bonutti | Jul 1999 | A |
5925064 | Meyers et al. | Jul 1999 | A |
5928244 | Tovey et al. | Jul 1999 | A |
5928267 | Bonutti et al. | Jul 1999 | A |
5931838 | Vito | Aug 1999 | A |
5931869 | Boucher et al. | Aug 1999 | A |
5940942 | Fong | Aug 1999 | A |
5941900 | Bonutti | Aug 1999 | A |
5941901 | Egan | Aug 1999 | A |
5944750 | Tanner | Aug 1999 | A |
5945002 | Bonutti | Sep 1999 | A |
5947982 | Duran | Sep 1999 | A |
5948000 | Larsen et al. | Sep 1999 | A |
5948001 | Larsen | Sep 1999 | A |
5951590 | Goldfarb | Sep 1999 | A |
5957953 | DiPoto et al. | Sep 1999 | A |
5961499 | Bonutti | Oct 1999 | A |
5961521 | Roger | Oct 1999 | A |
5961554 | Janson et al. | Oct 1999 | A |
5964765 | Fenton, Jr. et al. | Oct 1999 | A |
5964769 | Wagner et al. | Oct 1999 | A |
5968046 | Castleman | Oct 1999 | A |
5968047 | Reed | Oct 1999 | A |
5948002 | Bonutti | Nov 1999 | A |
5980520 | Vancaillie | Nov 1999 | A |
5980559 | Bonutti | Nov 1999 | A |
5984929 | Bashiri et al. | Nov 1999 | A |
5989282 | Bonutti | Nov 1999 | A |
5993458 | Vaitekunas et al. | Nov 1999 | A |
5993477 | Vaitekunas et al. | Nov 1999 | A |
6007567 | Bonutti | Dec 1999 | A |
6007580 | Lehto et al. | Dec 1999 | A |
6010525 | Bonutti et al. | Jan 2000 | A |
6010526 | Sandstrom et al. | Jan 2000 | A |
6017321 | Boone | Jan 2000 | A |
6033429 | Magovern | Mar 2000 | A |
6033430 | Bonutti | Mar 2000 | A |
6045551 | Bonutti | Apr 2000 | A |
6050998 | Fletcher et al. | Apr 2000 | A |
6056751 | Fenton, Jr. | May 2000 | A |
6056772 | Bonutti | May 2000 | A |
6056773 | Bonutti | May 2000 | A |
6059797 | Mears | May 2000 | A |
6059817 | Bonutti et al. | May 2000 | A |
6059827 | Fenton | May 2000 | A |
6063095 | Wang et al. | May 2000 | A |
6066151 | Miyawaki et al. | May 2000 | A |
6066160 | Colvin et al. | May 2000 | A |
6066166 | Bischoff et al. | May 2000 | A |
6068637 | Popov et al. | May 2000 | A |
6068648 | Cole | May 2000 | A |
6077277 | Mollenauer et al. | Jun 2000 | A |
6077292 | Bonutti | Jun 2000 | A |
6080161 | Eaves, III et al. | Jun 2000 | A |
6083522 | Chu et al. | Jul 2000 | A |
6086593 | Bonutti | Jul 2000 | A |
6086608 | Ek et al. | Jul 2000 | A |
6090072 | Kratoska et al. | Jul 2000 | A |
6099531 | Bonutti | Aug 2000 | A |
6099537 | Sugai et al. | Aug 2000 | A |
6099550 | Yoon | Aug 2000 | A |
6099552 | Adams | Aug 2000 | A |
6102850 | Wang et al. | Aug 2000 | A |
6106545 | Egan | Aug 2000 | A |
6117160 | Bonutti | Sep 2000 | A |
6120536 | Ding et al. | Sep 2000 | A |
6125574 | Ganaja et al. | Oct 2000 | A |
6126677 | Ganaja et al. | Oct 2000 | A |
6139320 | Hahn | Oct 2000 | A |
RE36974 | Bonutti | Nov 2000 | E |
6149669 | Li | Nov 2000 | A |
6152949 | Bonutti | Nov 2000 | A |
6155756 | Mericle et al. | Dec 2000 | A |
6159224 | Yoon | Dec 2000 | A |
6159234 | Bonutti et al. | Dec 2000 | A |
6171299 | Bonutti | Jan 2001 | B1 |
6171307 | Bonutti | Jan 2001 | B1 |
6174324 | Egan et al. | Jan 2001 | B1 |
6179840 | Bowman | Jan 2001 | B1 |
6179850 | Goradia | Jan 2001 | B1 |
6187008 | Hamman | Feb 2001 | B1 |
6190400 | Van De Moer et al. | Feb 2001 | B1 |
6190401 | Green | Feb 2001 | B1 |
6200322 | Branch et al. | Mar 2001 | B1 |
6217591 | Egan et al. | Apr 2001 | B1 |
6224593 | Ryan | May 2001 | B1 |
6224630 | Bao et al. | May 2001 | B1 |
6228086 | Wahl et al. | May 2001 | B1 |
6231592 | Bonutti et al. | May 2001 | B1 |
6238395 | Bonutti | May 2001 | B1 |
6238396 | Bonutti | May 2001 | B1 |
6258091 | Sevrain et al. | Jul 2001 | B1 |
6264675 | Brotz | Jul 2001 | B1 |
6267761 | Ryan | Jul 2001 | B1 |
6273717 | Hahn et al. | Aug 2001 | B1 |
6280474 | Cassidy et al. | Aug 2001 | B1 |
6286746 | Egan et al. | Sep 2001 | B1 |
6287325 | Bonutti | Sep 2001 | B1 |
6293961 | Schwartz et al. | Sep 2001 | B2 |
6306159 | Schwartz et al. | Oct 2001 | B1 |
6309405 | Bonutti | Oct 2001 | B1 |
6312448 | Bonutti | Nov 2001 | B1 |
6338730 | Bonutti et al. | Jan 2002 | B1 |
6340365 | Dittrich et al. | Jan 2002 | B2 |
6348056 | Bates et al. | Feb 2002 | B1 |
6358271 | Egan et al. | Mar 2002 | B1 |
6364897 | Bonutti | Apr 2002 | B1 |
6368325 | McKinley et al. | Apr 2002 | B1 |
6368343 | Bonutti et al. | Apr 2002 | B1 |
6371957 | Amrein et al. | Apr 2002 | B1 |
6409742 | Fulton, III | Jun 2002 | B1 |
6409743 | Fenton, Jr. | Jun 2002 | B1 |
6419704 | Ferree | Jul 2002 | B1 |
6423088 | Fenton | Jul 2002 | B1 |
6425919 | Lambrecht | Jul 2002 | B1 |
6428562 | Bonutti | Aug 2002 | B2 |
6432115 | Mollenauer et al. | Aug 2002 | B1 |
6447516 | Bonutti | Sep 2002 | B1 |
6450985 | Schoelling et al. | Sep 2002 | B1 |
6461360 | Adam | Oct 2002 | B1 |
6468293 | Bonutti et al. | Oct 2002 | B2 |
6475230 | Bonutti | Nov 2002 | B1 |
6488196 | Fenton | Dec 2002 | B1 |
6500195 | Bonutti | Dec 2002 | B2 |
6503259 | Huxel et al. | Jan 2003 | B2 |
6530933 | Yeung et al. | Mar 2003 | B1 |
6535764 | Imran et al. | Mar 2003 | B2 |
6544267 | Cole et al. | Apr 2003 | B1 |
6545390 | Hahn et al. | Apr 2003 | B1 |
6547792 | Tsuji et al. | Apr 2003 | B1 |
6551304 | Whalen et al. | Apr 2003 | B1 |
6551343 | Tormala | Apr 2003 | B1 |
6554852 | Oberlander | Apr 2003 | B1 |
6527774 | Lieberman | May 2003 | B2 |
6558390 | Cragg | May 2003 | B2 |
6568313 | Fukui et al. | May 2003 | B2 |
6569187 | Bonutti | May 2003 | B1 |
6572635 | Bonutti | Jun 2003 | B1 |
D477776 | Pontaoe | Jul 2003 | S |
6557426 | Reinemann et al. | Jul 2003 | B2 |
6585750 | Bonutti | Jul 2003 | B2 |
6592609 | Bonutti | Jul 2003 | B1 |
6594517 | Nevo | Jul 2003 | B1 |
6585764 | Wright et al. | Aug 2003 | B2 |
6602293 | Bierman | Aug 2003 | B1 |
6610080 | Morgan | Aug 2003 | B2 |
6605090 | Trieu et al. | Sep 2003 | B1 |
6618910 | Pontaoe | Sep 2003 | B1 |
6623487 | Goshert | Sep 2003 | B1 |
6626944 | Taylor | Sep 2003 | B1 |
6623486 | Weaver | Oct 2003 | B1 |
6632245 | Kim | Oct 2003 | B2 |
6635073 | Bonutti | Oct 2003 | B2 |
6638279 | Bonutti | Oct 2003 | B2 |
6641592 | Sauer et al. | Nov 2003 | B1 |
6645227 | Fallin et al. | Nov 2003 | B2 |
6666877 | Morgan et al. | Dec 2003 | B2 |
6669705 | Westhaver et al. | Dec 2003 | B2 |
6679888 | Green et al. | Jan 2004 | B2 |
6685750 | Plos et al. | Feb 2004 | B1 |
6699240 | Francischelli | Mar 2004 | B2 |
6702821 | Bonutti | Mar 2004 | B2 |
6705179 | Mohtasham | Mar 2004 | B1 |
6709457 | Otte | Mar 2004 | B1 |
6719765 | Bonutti | Apr 2004 | B2 |
6719795 | Cornwall | Apr 2004 | B1 |
6719797 | Ferree | Apr 2004 | B1 |
6722552 | Fenton | Apr 2004 | B2 |
6733531 | Trieu | May 2004 | B1 |
6764514 | Li et al. | Jul 2004 | B1 |
6770078 | Bonutti | Aug 2004 | B2 |
6780198 | Gregoire et al. | Aug 2004 | B1 |
6786989 | Torriani et al. | Sep 2004 | B2 |
6796003 | Marvel | Sep 2004 | B1 |
6818010 | Eichhorn et al. | Nov 2004 | B2 |
6823871 | Schmieding | Nov 2004 | B2 |
6830589 | Erickson | Dec 2004 | B2 |
6860885 | Bonutti | Mar 2005 | B2 |
6878167 | Ferree | Apr 2005 | B2 |
6893434 | Fenton et al. | May 2005 | B2 |
6899722 | Bonutti | May 2005 | B2 |
6890334 | Brace et al. | Jul 2005 | B2 |
6913666 | Aeschlimann et al. | Jul 2005 | B1 |
6916321 | TenHuisen | Jul 2005 | B2 |
6921264 | Mayer et al. | Jul 2005 | B2 |
6923824 | Morgan et al. | Aug 2005 | B2 |
6932835 | Bonutti | Aug 2005 | B2 |
6942684 | Bonutti | Sep 2005 | B2 |
6944111 | Nakamura et al. | Sep 2005 | B2 |
6955540 | Mayer et al. | Oct 2005 | B2 |
6955683 | Bonutti | Oct 2005 | B2 |
6958077 | Suddaby | Oct 2005 | B2 |
6981983 | Rosenblatt et al. | Jan 2006 | B1 |
6997940 | Bonutti | Feb 2006 | B2 |
7001411 | Dean | Feb 2006 | B1 |
7004959 | Bonutti | Feb 2006 | B2 |
7008226 | Mayer et al. | Mar 2006 | B2 |
7033379 | Peterson | Apr 2006 | B2 |
7048755 | Bonutti | May 2006 | B2 |
7066960 | Dickman | Jun 2006 | B1 |
7087073 | Bonutti | Aug 2006 | B2 |
7090111 | Egan et al. | Aug 2006 | B2 |
7094251 | Bonutti | Aug 2006 | B2 |
7104996 | Bonutti | Sep 2006 | B2 |
7128763 | Blatt | Oct 2006 | B1 |
7018380 | Cole | Dec 2006 | B2 |
7147652 | Bonutti et al. | Dec 2006 | B2 |
7160405 | Aeschlimann et al. | Jan 2007 | B2 |
7179259 | Gibbs | Feb 2007 | B1 |
7192448 | Ferree | Mar 2007 | B2 |
7217279 | Reese | May 2007 | B2 |
7217290 | Bonutti | May 2007 | B2 |
7241297 | Shaolian et al. | Jul 2007 | B2 |
7250051 | Francischelli | Jul 2007 | B2 |
7252685 | Bindseil et al. | Aug 2007 | B2 |
7273497 | Ferree | Sep 2007 | B2 |
7326200 | Trieu | Feb 2008 | B2 |
7329263 | Bonutti | Feb 2008 | B2 |
7335205 | Aeshcliamann | Feb 2008 | B2 |
7429266 | Bonutti | Sep 2008 | B2 |
7445634 | Trieu | Nov 2008 | B2 |
7481825 | Bonutti | Jan 2009 | B2 |
7481831 | Bonutti | Jan 2009 | B2 |
7510895 | Rateman | Mar 2009 | B2 |
7597705 | Forsberg et al. | Oct 2009 | B2 |
7854750 | Bonutti | Dec 2010 | B2 |
7879072 | Bonutti | Feb 2011 | B2 |
7891691 | Bearey | Feb 2011 | B2 |
7967820 | Bonutti | Jun 2011 | B2 |
8128669 | Bonutti | Mar 2012 | B2 |
8140982 | Hamilton, II et al. | Mar 2012 | B2 |
8147514 | Bonutti | Apr 2012 | B2 |
8162977 | Bonutti et al. | Apr 2012 | B2 |
8487844 | Koyama | Jul 2013 | B2 |
8771314 | Crombie | Jul 2014 | B2 |
8845699 | Bonutti | Sep 2014 | B2 |
20010002440 | Bonutti | May 2001 | A1 |
20010008971 | Schwartz | Jul 2001 | A1 |
20010009250 | Herman et al. | Jul 2001 | A1 |
20010041916 | Bonutti | Nov 2001 | A1 |
20010056287 | Bonutti | Dec 2001 | A1 |
20020016593 | Hearn et al. | Feb 2002 | A1 |
20020016633 | Lin et al. | Feb 2002 | A1 |
20020019649 | Sikora | Feb 2002 | A1 |
20020026244 | Trieu | Feb 2002 | A1 |
20020029067 | Bonutti | Mar 2002 | A1 |
20020029083 | Zucherman et al. | Mar 2002 | A1 |
20020029084 | Paul et al. | Mar 2002 | A1 |
20020045902 | Bonutti | Apr 2002 | A1 |
20020058966 | Tormala | May 2002 | A1 |
20020062153 | Paul et al. | May 2002 | A1 |
20020087189 | Bonutti | Jul 2002 | A1 |
20020103495 | Cole | Aug 2002 | A1 |
20020120269 | Lange | Aug 2002 | A1 |
20020123750 | Eisermann et al. | Sep 2002 | A1 |
20020161439 | Strobel | Oct 2002 | A1 |
20020183762 | Anderson et al. | Dec 2002 | A1 |
20020188301 | Dallara et al. | Dec 2002 | A1 |
20030039196 | Nakamura et al. | Feb 2003 | A1 |
20030040758 | Wang et al. | Feb 2003 | A1 |
20030065361 | Dreyfuss | Apr 2003 | A1 |
20030083667 | Ralph | May 2003 | A1 |
20030097148 | Valimaa | May 2003 | A1 |
20030105474 | Bonutti | Jun 2003 | A1 |
20030118518 | Hahn et al. | Jun 2003 | A1 |
20030125749 | Yuan | Jul 2003 | A1 |
20030158555 | Sanders | Aug 2003 | A1 |
20030158582 | Bonutti et al. | Aug 2003 | A1 |
20030167072 | Oberlander | Aug 2003 | A1 |
20030181800 | Bonutti | Sep 2003 | A1 |
20030195514 | Trieu | Oct 2003 | A1 |
20030195530 | Thill | Oct 2003 | A1 |
20030195565 | Bonutti | Oct 2003 | A1 |
20030204204 | Bonutti | Oct 2003 | A1 |
20030208203 | Lim | Nov 2003 | A1 |
20030216742 | Wetzler et al. | Nov 2003 | A1 |
20030225438 | Bonutti et al. | Dec 2003 | A1 |
20030229361 | Jackson | Dec 2003 | A1 |
20040010287 | Bonutti | Jan 2004 | A1 |
20040024459 | Ferree | Feb 2004 | A1 |
20040030341 | Aeschlimann et al. | Feb 2004 | A1 |
20040034357 | Beane et al. | Feb 2004 | A1 |
20040039392 | Trieu | Feb 2004 | A1 |
20040220616 | Bonutti | Feb 2004 | A1 |
20040230223 | Bonutti | Feb 2004 | A1 |
20040049207 | Goldfarb | Mar 2004 | A1 |
20040097939 | Bonutti | May 2004 | A1 |
20040098050 | Foerster et al. | May 2004 | A1 |
20040102788 | Huebner | May 2004 | A1 |
20040116963 | Lattouf | Jun 2004 | A1 |
20040138703 | Alleyne | Jul 2004 | A1 |
20040138705 | Heino | Jul 2004 | A1 |
20040143334 | Ferree | Jul 2004 | A1 |
20040167548 | Bonutti | Aug 2004 | A1 |
20040172063 | Li | Sep 2004 | A1 |
20040186471 | Trieu | Sep 2004 | A1 |
20040225325 | Bonutti | Nov 2004 | A1 |
20040236374 | Bonutti et al. | Nov 2004 | A1 |
20050033362 | Grafton | Feb 2005 | A1 |
20050033366 | Cole | Feb 2005 | A1 |
20050038514 | Helm et al. | Feb 2005 | A1 |
20050043733 | Eisermann | Feb 2005 | A1 |
20050043796 | Grant et al. | Feb 2005 | A1 |
20050070765 | Abdelgany | Mar 2005 | A1 |
20050071012 | Serhan et al. | Mar 2005 | A1 |
20050075644 | DiPoto | Apr 2005 | A1 |
20050090827 | Gedebou | Apr 2005 | A1 |
20050096699 | Wixey et al. | May 2005 | A1 |
20050113928 | Cragg et al. | May 2005 | A1 |
20050125072 | Kolb | Jun 2005 | A1 |
20050126680 | Aeschlimann et al. | Jun 2005 | A1 |
20050143826 | Zucherman et al. | Jun 2005 | A1 |
20050240227 | Bonutti | Jun 2005 | A1 |
20050149024 | Ferrante et al. | Jul 2005 | A1 |
20050149029 | Bonutti | Jul 2005 | A1 |
20050203521 | Bonutti | Sep 2005 | A1 |
20050216059 | Bonutti | Sep 2005 | A1 |
20050216087 | Zucherman et al. | Sep 2005 | A1 |
20050222620 | Bonutti | Oct 2005 | A1 |
20050234460 | Miller | Oct 2005 | A1 |
20050240190 | Gall et al. | Oct 2005 | A1 |
20050246021 | Ringeisen et al. | Nov 2005 | A1 |
20050256582 | Ferree | Nov 2005 | A1 |
20050261684 | Shaolian et al. | Nov 2005 | A1 |
20050267481 | Carl et al. | Dec 2005 | A1 |
20050267534 | Bonutti | Dec 2005 | A1 |
20050283246 | Cauthen | Dec 2005 | A1 |
20060009846 | Trieu | Jan 2006 | A1 |
20060009855 | Goble et al. | Jan 2006 | A1 |
20060015101 | Warburton et al. | Jan 2006 | A1 |
20060015108 | Bonutti | Jan 2006 | A1 |
20060024357 | Carpenter et al. | Feb 2006 | A1 |
20060026244 | Watson | Feb 2006 | A1 |
20060142799 | Bonutti | Feb 2006 | A1 |
20060200199 | Bonutti | Feb 2006 | A1 |
20060229623 | Bonutti | Feb 2006 | A1 |
20060064095 | Senn et al. | Mar 2006 | A1 |
20060167495 | Bonutti | Mar 2006 | A1 |
20060089646 | Bonutti | Apr 2006 | A1 |
20060122600 | Cole | Jun 2006 | A1 |
20060122704 | Vresilovic et al. | Jun 2006 | A1 |
20060235470 | Bonutti | Jul 2006 | A1 |
20060241695 | Bonutti | Jul 2006 | A1 |
20060265009 | Bonutti | Jul 2006 | A1 |
20060265011 | Bonutti | Jul 2006 | A1 |
20060189982 | Lange | Aug 2006 | A1 |
20060212073 | Bonutti | Sep 2006 | A1 |
20060217765 | Bonutti | Sep 2006 | A1 |
20060235413 | Denham | Oct 2006 | A1 |
20060264953 | Falahee | Nov 2006 | A1 |
20070032825 | Bonutti et al. | Feb 2007 | A1 |
20070088362 | Bonutti et al. | Apr 2007 | A1 |
20070118129 | Fraser et al. | May 2007 | A1 |
20070198555 | Friedman et al. | Aug 2007 | A1 |
20070233092 | Falahee | Oct 2007 | A1 |
20070265561 | Yeung | Nov 2007 | A1 |
20070270833 | Bonutti | Nov 2007 | A1 |
20080021474 | Bonutti et al. | Jan 2008 | A1 |
20080039845 | Bonutti | Feb 2008 | A1 |
20080039873 | Bonutti | Feb 2008 | A1 |
20080046090 | Paul et al. | Feb 2008 | A1 |
20080195145 | Bonutti | Feb 2008 | A1 |
20080097448 | Binder et al. | Apr 2008 | A1 |
20080108897 | Bonutti et al. | May 2008 | A1 |
20080108916 | Bonutti | May 2008 | A1 |
20080114399 | Bonutti | May 2008 | A1 |
20080132950 | Lange | Jun 2008 | A1 |
20080140116 | Bonutti | Jun 2008 | A1 |
20080140117 | Bonutti | Jun 2008 | A1 |
20080269753 | Cannestra | Oct 2008 | A1 |
20080269808 | Gall et al. | Oct 2008 | A1 |
20080288070 | Lo | Nov 2008 | A1 |
20090024161 | Bonutti | Jan 2009 | A1 |
20090138014 | Bonutti | Jan 2009 | A1 |
20090093684 | Schorer | Apr 2009 | A1 |
20090194969 | Bearey | Aug 2009 | A1 |
20100211120 | Bonutti | Feb 2010 | A1 |
20100262185 | Gelfand | Oct 2010 | A1 |
20110060375 | Bonutti | Mar 2011 | A1 |
20110295253 | Bonutti et al. | Dec 2011 | A1 |
20120130492 | Eggli | May 2012 | A1 |
20120165841 | Bonutti | Jun 2012 | A1 |
20120191140 | Bonutti | Jul 2012 | A1 |
20120215233 | Bonutti et al. | Aug 2012 | A1 |
Number | Date | Country |
---|---|---|
2641580 | Aug 2007 | CA |
2680827 | Sep 2008 | CA |
2698057 | Mar 2009 | CA |
1903016 | Oct 1964 | DE |
1903316 | Oct 1964 | DE |
1903016 | Aug 1970 | DE |
3517204 | Nov 1986 | DE |
3722538 | Jan 1989 | DE |
9002844 | Jan 1991 | DE |
784454 | May 1996 | EP |
773004 | May 1997 | EP |
1614525 | Jan 2006 | EP |
1988837 | Aug 2007 | EP |
2134294 | Dec 2009 | EP |
2717368 | Mar 1994 | FR |
2696338 | Apr 1994 | FR |
2728779 | Jan 1995 | FR |
2736257 | Jul 1995 | FR |
2750031 | Jun 1996 | FR |
2771621 | Nov 1997 | FR |
2785171 | Oct 1998 | FR |
2093701 | Sep 1982 | GB |
2306110 | Apr 1997 | GB |
8140982 | Jun 1996 | JP |
184396 | Jul 1966 | SU |
9112779 | Sep 1991 | WO |
9323094 | Nov 1993 | WO |
WO1994008642 | Apr 1994 | WO |
9516398 | Jun 1995 | WO |
WO 9531941 | Nov 1995 | WO |
WO1996014802 | May 1996 | WO |
WO1997012779 | Apr 1997 | WO |
9749347 | Dec 1997 | WO |
WO 9749347 | Dec 1997 | WO |
WO1998011838 | Mar 1998 | WO |
WO1998026720 | Jun 1998 | WO |
WO2002053011 | Jul 2002 | WO |
2007092869 | Aug 2007 | WO |
2007092869 | Aug 2007 | WO |
2008116203 | Sep 2008 | WO |
2009029908 | Mar 2009 | WO |
2009124215 | Oct 2009 | WO |
WO2010099222 | Feb 2010 | WO |
Entry |
---|
Copending U.S. Appl. No. 11/932,907—RCE Response dated Sep. 15, 2011. |
Copending U.S. Appl. No. 11/258,795 Non-Final Office Action dated Apr. 26, 2011. |
Copending U.S. Appl. No. 11/689,670, RCE Response dated Sep. 19, 2011. |
European Search Report dated Sep. 10, 2012 for EP08732724.3. |
Copending U.S. Appl. No. 10/614,352, Final Office Action dated Jul. 12, 2010. |
Copending U.S. Appl. No. 11/932,602 Final Response to Office Action dated Jun. 10, 2011. |
Copending U.S. Appl. No. 11/671,556 Response filed Aug. 23, 2010. |
Co-pending U.S. Appl. No. 11/438,537, Supplemental Final Rejection dated Sep. 25, 2009. |
Arthrex, Protect your graft, Am J Sports Med, vol. 22, No. 4, Jul.-Aug. 1994. |
Barrett et al, T-Fix endoscopic meniscal repair: technique and approach to different types of tears, Apr. 1995, Arthroscopy vol. 11 No. 2 p. 245-51. |
Cope, Suture Anchor for Visceral Drainage, AJR, vol. 148 p. 160-162, Jan. 1986. |
Gabriel, Arthroscopic Fixation Devices, Wiley Enc. of Biomed Eng., 2006. |
Innovasive, We've got you covered, Am J Sports Med, vol. 26, No. 1, Jan.-Feb. 1998. |
510k—TranSet Fracture Fixation System, Feb. 24, 2004, k033717. |
510k—Linvatec Biomaterials modification of Duet and impact Suture Anchor, Nov. 19, 2004, k042966. |
510k, arthrex pushlock, Jun. 29, 2005, K051219. |
510k, mitek micro anchor, Nov. 6, 1996, K962511. |
510k, Multitak Suture System, Jan. 10, 1997, K964324. |
510k, Modified Mitek 3.5mm Absorbable Suture Anchor System, Jun. 9, 1997, K970896. |
510K, Summary for Arthrex Inc.'s Bio-Interference Screw, Jul. 9, 1997, K971358. |
510k, Surgicraft Bone Tie, Sep. 25, 1998, K982719. |
Karlsson et al, Repair of Bankart lesions with a suture anchor in recurrent dislocation of the shoulder, Scand. j. of Med & Science in Sports, 1995, 5:170-174. |
Madjar et al, Minimally Invasive Pervaginam Procedures, for the Treatment of Female Stress Incontinence . . . , Artificial Organs, 22 (10) 879-885, 1998. |
Nowak et al, Comparative Study of Fixation Techniques in the Open Bankart Operation Using Either a Cannulated Screw or Suture-Anchors, Acta Orthopcedica Belgica, vol. 64—Feb. 1998. |
Packer et al, Repair of Acute Scapho-Lunate Dissociation Facilitated by the “Tag.” Suture Anchor, Journal of Hand Surgery (British and European vol. 1994) 19B: 5: 563-564. |
Richmond, Modificatio of the Bankart reconstruction with a suture anchor, Am J Sports Med, vol. 19, No. 4, p. 343-346, 1991. |
Shea et al, Technical Note: Arthroscopic Rotator Cuff Repair Using a Transhumeral Approach to Fixation, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 14, No. 1 Jan.-Feb. 1998: pp. 118-122. |
Tfix, Acufex just tied the knot . . . , Am. J. Sports Med., vol. 22, No. 3, May-Jun. 1994. |
Wong et al, Case Report: Proper Insertion Angle Is Essential to Prevent Intra-Articular Protrusion of a Knotless Suture Anchor in Shoulder Rotator Cuff Repair, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 26, No. 2 Feb. 2010: pp. 286-290. |
Cobb et al, Late Correction of Malunited Intercondylar Humeral Fractures Intra-Articular Osteotomy and Tricortical Bone Grafting, J BoneJointSurg [Br] 1994; 76-B:622-6. |
Fellinger, et al, Radial avulsion of the triangular fibrocartilage complex in acute wrist trauma: a new technique for arthroscopic repair, Jun. 1997, Arthroscopy vol. 13 No. 3 p. 370-4. |
Hecker et al , Pull-out strength of suture anchors for rotator cuff and Bankart lesion repairs, Nov.-Dec. 1993 , The American Journal of Sports Medicine, vol. 21 No. 6 p. 874-9. |
Hernigou et al , Proximal Tibial Osteotomy for Osteoarthritis with Varus Deformity a Ten to Thirteen-Year Follow-Up Study, J Bone Joint Surg, vol. 69-A, No. 3. Mar. 1987, p. 332-354. |
Ibarra et al, Glenoid Replacement in Total Shoulder Arthroplasty, The Orthopedic Clinics of Northamerica: Total Shoulder Arthroplasty, vol. 29 No. 3, Jul. 1998 p. 403-413. |
Mosca et al, Calcaneal Lengthening for Valgus Deformity of the Hindfoot: Results in Children Who Had Severe, Symptomatic fLATFOOT and Skewfoot, J Bone Joint Surg,, 1195—p. 499-512. |
Murphycet al , Radial Opening Wedge Osteotomy in Madelung's Deformity, J. Hand Surg, vol. 21 A No. 6 Nov. 1996, p. 1035-44. |
Biomet, Stanmore Modular Hip, J. Bone Joint Surg., vol. 76-B : No. Two, Mar. 1994. |
Intl Prelim Rep on Patentability and Written Opinion for PCT/US10/25263 dated Aug. 30, 2011. |
IPR—International Publication WO/2008/116203, published Sep. 22, 2009 for PCT/US08/57948. |
ISR—International Search Report WO/2008/116203, published Dec. 24, 2008 for PCT/US08/57948. |
IPER—Internation Preliminary Report on Patentability, WO/2008/116203, published Sep. 22, 2009 for PCT/US08/57948. |
Written Opinion WO/2008/116203 dated Oct. 23, 2008 for PCT/US08/57948. |
IPR—International Publication WO2009/029908, published May 3, 2009 for PCT/US08/74941. |
ISR—International Search Report, WO2009/029908, published May 3, 2009 for PCT/US08/74941. |
IPER—Internation Preliminary Report on Patentability, WO2009/029908, published Mar. 2, 2010 for PCT/US08/74941. |
Written Opinion WO2009/029908 dated Feb. 28, 2010 for PCT/US08/74941. |
International Search Report PCT/US2010/025263 completed Apr. 13, 2010. |
Written Opinion for PCT/US2010/025263 completed Apr. 13, 2010. |
The Search for the Holy Grail: A Centrury of Anterior Cruciate Ligament Reconstruction, R. John Naranja, American Journal of Orthopedics, Nov. 1997. |
Femoral Bone Plug Recession in Endoscope Anterior Cruciate Ligament Reconstruction, David E. Taylor, Arthroscopy: The Journal of Arthroscopic and Related Surgery, Aug. 1996. |
Meniscus Replacement with Bone Anchors: A Surgical Technique, Arthroscopy: The Journal of Arthroscopic and Related Surgery, 1994. |
Problem Solving Report Question No. 1014984.066, Ultrasonic Welding, (c) 1999. |
Guide to Ultrasound Plastic Assembly, Ultrasonic Division Publication, (c) 1995. |
Branson, Polymers: Characteristics and Compatibility for Ultrasonic Assembly, Applied Technologies Group, Publication unknown. |
Enabling Local Drug Delivery-Implant Device Combination Therapies, Surmodics, Inc., (c) 2003. |
Stent Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model, Takeshi Suzuki, American Heart Association, Inc. (c) 2001. |
Why Tie a Knot When You Can Use Y-Knot?, Innovasive Devices Inc., (c) 1998. |
Ask Oxford, compact Oxford English dictionary: projection, Mar. 30, 2009. |
Ask Oxford, compact Oxford English dictionary: slit, Mar. 30, 2009. |
Textured Surface Technology, Branson Technolog, Branson Ultrasonics Copr., (c) 1992. |
IPR—International Publication WO/2007/092869, publishedAug. 16, 2007 for PCT/US2007/061730. |
ISR—International Search Report WO/2007/092869, published Dec. 13, 2007 for PCT/US2007/061730. |
Intl Prelim Report on Patentability, WO/2007/092869, published Aug. 12, 2008 for PCT/US2007/061730. |
Written Opinion WO/2007/092869 dated Aug. 7, 2008 for PCT/US2007/061730. |
Petition for Inter Partes Review of U.S. Pat. No. 5,980,559, IPR 2013-00603, Filing Date Sep. 24, 2013. |
Declaration of David Kaplan, Ph.D. Regarding U.S. Pat. No. 5,980,559, IPR 2013-00603, Sep. 24, 2013. |
Petition for Inter Partes Review of U.S. Pat. No. 7,087,073, IPR 2013-00604, Filing Date Sep. 24, 2013 |
Declaration of Wayne J. Sebastianelli, MD Regarding U.S. Pat. No. 7,087,073, Sep. 24, 2013, IPR 2013-00604. |
Petition for Inter Partes Review of U.S. Pat. No. 6,500,195, IPR 2013-00624, Filing Date Oct. 2, 2013. |
Declaration of Dr. Philip Hardy in Support of Petition for Inter Partes Review of U.S. Pat. No. 6,500,195, IPR 2013-00624, Sep. 25, 2013. |
Petition for Inter Partes Review of U.S. Pat. No. 5,527,343, IPR 2013-00628, Filing Date Sep. 26, 2013, Sep. 25, 2013. |
Declaration of Dr. Philip Hardy in Support of Petition for Inter Partes Review of U.S. Pat. No. 5,527,343, IPR 2013-00628, Sep. 25, 2013. |
Corrected Petition for Inter Partes Review of U.S. Pat. No. 5,921,986, IPR 2013-00631, Filing Date Sep. 27, 2013. |
Expert Declaration of Steve E. Jordan, MD, for Inter Partes Review of U.S. Pat. No. 5,921,986, IPR 2013-00631, Sep. 24, 2013. |
Corrected Petition for Inter Partes Review of U.S. Pat. No. 8,147,514, IPR 2013-00632, Filing Date Sep. 27, 2013. |
Declaration of Steve Jordan for U.S. Pat. No. 8,147,514, from IPR 2013-00632, dated Sep. 23, 2013 (exhibit 1009). |
Corrected Petition for Inter Partes Review of U.S. Pat. No. 8,147,514, IPR 2013-00633, Filing Date Sep. 27, 2013. |
Declaration of Steve Jordan for U.S. Pat. No. 8,147,514, from IPR 2013-00633, dated Sep. 23, 2013 (exhibit 1006). |
Flory, Principles of Polymer Chemistry, 1953, selected pages (cited in IPR 2013-00603, exhibit 1012). |
Grizzi, Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence, Biomaterials, 1995, vol. 16, No. 4, p. 305-11 (cited in IPR 2013-00603, exhibit 1006). |
Gopferich, Mechanisms of polymer degradation and erosion, Biomaterials, 1996, vol. 17, No. 2, p. 103-114 (cited in IPR 2013-00603, exhibit 1013). |
Gao et el, Swelling of Hydroxypropyl Methylcellulose Matrix Tablets . . . , J. of Pharmaceutical Sciences, vol. 85, No. 7, Jul. 1996, p. 732-740 (cited in IPR 2013-00603, exhibit 1014). |
Linvatec, Impact Suture Anchor brochure, 2004 (cited in IPR 2013-00628, exhibit 1010). |
Seitz et al, Repair of the Tibiofibular Syndesmosis with a Flexible Implant, J. of Orthopaedic Trauma, vol. 5, No. 1, p. 78-82, 1991 (cited in IPR 2013-00631, exhibit 1007) (cited in 2013-00632). |
Translation of FR2696338 with translators certificate dated Sep. 17, 2013 (cited in IPR 2013-00631, 2013-00632). |
Translation of DE9002844.9 with translator's certificate dated Sep. 26, 2013 (cited in IPR 2013-00631, 2013-00632). |
Declaration of Steve Jordan for U.S. Pat. No. 5,921,986, from IPR 2013-00632, dated Sep. 24, 2013 (exhibit 1010). |
Declaration of Steve Jordan for U.S. Pat. No. 5,921,986, from IPR 2013-00633, dated Sep. 24, 2013 (exhibit 1007). |
Declaration of Dr. Steve E. Jordan for U.S. Pat. No. 8,147,514, from IPR 2013-00631, dated Sep. 23, 2013. |
Number | Date | Country | |
---|---|---|---|
20140194907 A1 | Jul 2014 | US |
Number | Date | Country | |
---|---|---|---|
61749261 | Jan 2013 | US |